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Abstract 
Researcher: Nicholas James Stapleton 
Title:   Pre-exposure training as a means to reduce vection induced symptoms of motion 
sickness  
Institution: Embry-Riddle Aeronautical University 
Degree: Master of Science in Human Factors and Systems 
Year:  2013 
The focus of this study was designed to empirically examine the effect of inducing mild 
motion sickness as an ameliorative to a more severe motion sickness exposure. Twenty-seven 
participants were selected for this study based upon their susceptibility to motion sickness, that 
is, only people who were determined to be motion susceptible were tested. All participants were 
exposed to a motion sickness-inducing environment. Eighteen participants were trained to adapt 
to motion sickness by exposure to a milder motion sickness-inducing environment, ending either 
6 hours or 24 hours prior to the more severe motion test environment. 
Participants during the pre-exposure experimental conditions were trained to perform a 
mild motion sickness procedure, the Coriolis illusion.  Following this training period, all 
participants were exposed to the motion sickness testing environment; the optokinetic drum. 
Tests results were measured subjectively through a conventional motion sickness questionnaire 
and objectively through the use of a cognitive test, balance tests, and salivary markers for 
cortisol and amylase. A series of statistical analyses were conducted to compare the no motion 
pre-exposure condition to the other mild pre-exposure conditions in their measures from the 
motion sickness testing environment using both parametric and non-parametric tests.   Based 
upon prior research, it was hypothesized that the subjective responses, cognitive performance, 
 v 
 
and biomarkers for motion sickness would decrease and balance would increase for the 6 and 12 
hour exposures relative to the no pre-exposure condition.    
 The results indicated that the SSQ, Cortisol levels, SSS, and Finger to Nose Test were the 
only measures that captured the onset of motion sickness, and the SSQ was the only measure that 
identified any difference between training and non training groups. The SSQ indicated that 
recovery from motion sickness occurred at a faster rate following OKD exposure if the 
participant had training prior to exposure. No differences in symptoms were shown between the 
6 hour and 24 hour training groups. The results may help to identify a more effective 
countermeasure to improve perceptual training in motion sickness inducing environments. 
Theoretical and practical implications are also presented. 
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Introduction 
The human desire to explore has always pushed the limits of human ingenuity and 
physical ability.  The great journeys across the Atlantic Ocean in the 16
th
 century and the arctic 
explorations by ship of the 19
th
 century, for example, tried human endurance using the latest 
technology. During the last half century humans have begun to explore space.  In space 
exploration, human adaptation to microgravity has proven challenging.  Space Adaptation 
Syndrome (SAS) is one of these adaptations and manifests as motion sickness in the 
microgravity environment (Smither, Mouloua, & Kennedy, 2008).  Currently, pharmaceutical 
countermeasures against motion sickness only slightly dilute this problem.  They usually 
interfere with cognitive ability, and can even have adverse effects since the impact of 
microgravity on absorption, distribution, or elimination of these drugs is not well known 
(Gandia, Saivin, & Houin, 2005).  
This study evaluates the use of a behavioral countermeasure to motion disruption, that of 
pre-exposure to a less intense motion disruption than the anticipated motion sickness inducing 
event.  This study could have implications for other human endeavors where motion sickness 
(microgravity, simulators, boats, airplanes) is restrictive.  First a thorough background in motion 
sickness physiology is described then the most effective current countermeasures for motion 
disruption are discussed, and finally the hypotheses to be tested are stated. 
 
Significance of the Study 
 This study was used to further analyze the impact of pre-exposure training on symptoms 
in a motion sickness inducing environment. The results of this study have implications in a wide 
variety of fields from shipping and cruise lines to aircraft operations to videogame and 
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simulators to space operations as motion sickness is an obstacle for safe operations in all 
environments where motion sickness can occur. Proper research into mitigating motion sickness 
symptoms can significantly improve comfort and safety in these environments. This study 
examines one way to mitigate motion sickness symptoms without the side effects that come with 
various pharmacological countermeasures. This study will also identify which measures have the 
sensitivity to identify differences between different groups.  
 
Statement of the Problem 
 There are numerous motion sickness inducing environments which any given person may 
come across, including rough seas, simulators, and perhaps outer space in the near future.  
Motion sickness is a serious challenge to space exploration in the near future due to the impacts 
it has on safety, and the recent expansion of commercial space companies could mean more 
people flying into space. On Earth, the reliance on simulators for reduced training costs can lead 
to a form of motion sickness known as simulator sickness (Kennedy, Fowlkes, & Lilienthal, 
1993).  Ocean cruise lines have long been familiar with illness related to motion disruption as 
well, and the advent of space tourism will surely face the same challenges as sea travel, 
increasing our experiences of motion sickness (Stevens & Parsons, 2002). Research into 
mitigating motion sickness symptoms could significantly improve the comfort and safety in each 
of these environments.  
 
Purpose Statement 
 The purpose of this study was to identify whether pre-exposure training had a significant 
impact on the symptoms of motion sickness. Additionally, different methods of measuring 
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motion sickness symptoms were evaluated for their sensitivity to changes between groups. The 
evaluations were conducted using an Optokinetic Drum (OKD) to induce motion sickness in a 
controlled laboratory environment.  
 
Hypotheses and statistical design 
This study used a between-groups design consisting of 3 groups: a control condition with 
no training, an experimental group receiving pre-exposure training ending 6 hours prior to OKD 
exposure, and another experimental group receiving pre-exposure training ending 24 hours prior 
to OKD exposure. Participants were each tested in the OKD once. The experimental groups of 
participants received a mild pre-exposure to an event designed to induce motion sickness known 
as the Coriolis illusion. The length of time following exposure of 24 hours was necessary to be 
compatible with Mouloua, Smither, Kennedy, Kennedy, Compton, & Drexler (2005), which 
found 24 hours to be effective in improving motion sickness symptoms in both the OKD and in 
virtual reality environments.  
It was hypothesized that both pre-training groups (6 hours or 24 hours prior to OKD 
exposure) would experience a reduction in motion sickness symptoms associated with OKD 
exposure. It was additionally hypothesized that the impact of the countermeasures would be the 
more effective in the 6 hour after pre-training, because would be the exposure closest to the end 
of training. Similarly, the least effective pre-exposure training would be the 24 hour after training 
group, as the exposure would be the longest time after training. It was further hypothesized that 
cortisol and amylase measurements would be positively correlated with the severity of motion 
sickness symptoms.   
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Delimitations 
The subjective measures were evaluated using a Kruskal-Wallis and Mann-Whitney non-
parametric tests because of the ordinal nature of the data. All other objective measures were 
evaluated using an analysis of variance. 
 
Power Analysis. The power analyses conducted in this study were performed using an 
adjusted power estimator for t-tests. According to Lehmann (2006), so long as homogeneity of 
variance is not violated, a power estimator for the t-test can be used to estimate power for the 
corresponding nonparametric test, the Mann-Whitney test. This adjustment takes the form of a 
difference in sample size. The correction on the sample size for the Mann-Whitney test (Nu) is 
equal to the sample size used in the corresponding t-test (Nt) divided by the asymptotic relative 
efficiency (A.R.E.), or Pitman efficiency, of the Mann-Whitney test, resulting in the formula of 
Nu = Nt / A.R.E. (Lehmann, 2006). According to Lehmann (2006), the A.R.E. of the Mann-
Whitney test is equal to .955. The calculated Nu is then used in the standard power analysis for t-
tests in place of the sample size. This study was using Mann-Whitney tests to analyze SSQ Total 
scores and the Nonparametric Lavine test indicated that homogeneity of variance was not 
violated. The difference between the resulting power values calculated from the parametric test 
was less than .1% higher than the nonparametric results.  
 
Limitations and Assumptions 
 My limitations and assumptions are due to budgetary constraints, the size of the 
participant groups, and time constraints, measures such as melatonin were cut from the original 
study. Due to the limited budget, a single salivary sample was collected immediately prior to 
5 
 
 
 
OKD exposure rather than a resting day baseline. This meant that a baseline was only taken 
immediately prior to OKD exposure, and could possibly impact the results of the salivary 
cortisol and amylase levels. Additionally, participants were not tested beyond 30 minutes 
following exposure to the motion sickness inducing environment, except with the Simulator 
Sickness Questionnaire (SSQ) to determine if a participant was fit to leave, when applicable.  
 
Definition of Terms 
Asymptotic relative efficiency: The assumed adjustment needed when converting the 
sample size of a nonparametric test to its corresponding parametric test 
when calculating the result of a power estimator (Lehman, 2006). 
Behavioral Countermeasure: Countermeasures of motion sickness that do not rely on the 
use of pharmaceutical means (Yen Pik Sang, Billar, Golding and Gresty, 
2003). 
Imagineer: A person who devises and implements a new or highly imaginative 
concept or technology, in particular one who devises the attractions in 
Walt Disney theme parks (OED Online, 2013). 
Pharmaceutical Countermeasure: Countermeasures of motion sickness that involve the 
use of substances created or used to mitigate the symptoms or 
susceptibility to motion sickness (Takeda et al., 1993). 
Pittman efficiency: See asymptotic relative efficiency. 
Simulator Sickness: A type of motion sickness that occurs due to the effects of simulators 
on the human body (Kennedy, Fowlkes, & Lilienthal, 1993). 
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Vection: A specific type of simulator sickness where apparent motion causes the 
symptoms (Smither, Mouloua, & Kennedy, 2008). 
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Review of the Relevant Literature 
Motion Sickness 
 Motion sickness has affected humanity for as long as humans have used modes of 
transportation other than walking.  The term motion sickness does not adequately describe the 
condition, since the symptoms are not associated with a true sickness, but a normal response to a 
disturbance of proprioceptive feedback.  Symptoms can range from a mild inconvenience of a 
headache or nausea to temporary incapacitation.  General symptoms include nausea, eyestrain, 
blurred vision, headache, vertigo, and stomach concerns (Kennedy, Lane, Berbaum, & Lilienthal, 
1993).  Less familiar symptoms, such as Sopite Syndrome (malaise), oscillopsia and retinal slip 
(which are related to difficulty focusing the eyes), and postural instability (commonly called the 
leans) can also occur (Kennedy, Massey, & Lilienthal, 1995).  Any unusual or illusory motion 
can also cause motion sickness.  Symptom severity and susceptibility vary greatly from person to 
person, and even within an individual experiencing different causes of motion sickness (Stevens 
& Parsons, 2002).   
 
Causes. Not everyone susceptible to motion sickness succumbs to symptoms while 
experiencing every type of motion sickness each time. Most of the causes are fairly well known. 
Sea sickness has been around as long as humans have taken to the sea. The word nausea stems 
from naus, the Greek word for ship, literally translating to “the sickness of ships” (Merriam-
Webster, 2008). The loping camel is another ancient source of motion sickness for riders without 
experience on the sea (Stevens & Parsons, 2002). As time passed, humans continued to suffer 
from sea sickness as well as new forms of motion sickness from the technology that we created. 
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Besides sea sickness, the most common cause of motion sickness over the past 100 years has 
come from passengers in ships, automobiles and aircraft.  
Modern technology has provided many new ways for people to get motion sick. The 
advancement of virtual reality and computer simulated environments has been impacted by 
motion sensitivity. Simulator sickness has become a very common term in the modern world and 
has been a challenge ranging from programmers building virtual environments to Imagineers at 
Walt Disney World making live-action simulator rides. The apparent motion that causes 
symptoms in the case of simulator sickness is known as vection. As technology pushes the 
boundary of what motion experiences we encounter, considerations should be made to ensure 
that those exposed are not impaired by the cognitive and physical debilitations of motion 
sickness. 
When astronauts first arrive in space, they experience something that they have never felt 
for an extended time, the lack of a significant gravity. There are many physiological issues 
associated with extended exposure to a microgravity environment, including muscle atrophy, 
compromised immune systems and disorientation. Presumably, disruption of the proprioception 
system is ultimately the cause of motion sickness by the occasionally intense mismatch of 
vestibular, ocular and kinesthetic sensory information. In space, the sensory confusion can lead 
to motion sickness known as Space Adaptation Syndrome (SAS), which can last from 2-4 days, 
preventing astronauts from performing potentially mission essential tasks (for example, 
emergency egress). Approximately 70% of astronauts suffer symptoms of SAS, but eventually, 
all astronauts and their proprioception system adapts to the new microgravity environment of 
space and they stop reporting symptoms (Lackner & DiZio, 2006). 
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It is prohibitively expensive to simulate the conditions that generate SAS on the earth but 
perhaps parallels exist in laboratory techniques for inducing motion sickness.  This would allow 
humans to test SAS countermeasures without the costs and dangers of space travel. An 
Optokinetic Drum (OKD) is able to induce a similar type of motion sickness through vection in a 
safe, laboratory environment producing a similar pattern of symptoms at SAS. Because they are 
both motion sickness, it is likely that if pretreatment improves the symptoms caused by the 
OKD, then pretreatment will also improve symptoms of SAS. 
One particularly strong example of the hazards of SAS became clear on STS-51-D, when 
United States Senator Jake Garn flew on Space Shuttle Discovery as a congressional observer 
and payload specialist. During Senator Garn’s flight, he suffered from the strongest symptoms of 
SAS NASA has on record. Astronauts within NASA jokingly use “one Garn” as a measuring 
stick for the worst SAS symptoms can get, where most astronauts will reach a tenth of a Garn in 
their symptoms (Butler & Stevenson, 1999). 
  
 Special Symptoms. Some side effects of motion sickness are less known than the general 
symptoms listed above, though they are no less consequential. These include Sopite Syndrome, 
oscillopsia, retinal slip, and postural instability. These symptoms can be troubling for both 
earthbound forms of motion sickness, as well as SAS.  
 Sometimes the only symptom of motion sickness experienced is a condition known as 
Sopite Syndrome. This condition is characterized by drowsiness, fatigue, and in long-term cases, 
mental depression. A study by Graybiel & Knepton (1976) found significant evidence to show 
that fatigue and drowsiness manifest in acute, or short-term, motion sickness, and mental 
depression may manifest as well during long term, or chronic, exposure to motion sickness 
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stimuli. This symptom of motion disruption is not easily recognized as originating from a motion 
experience (Graybiel & Knepton, 1976).  
 Motion of the eyes also is a commonly overlooked symptom of motion sickness. One 
measure of retinal slip is the amount of motion the eye sees during movement. Normally, the eye 
can compensate for motion to keep acuity when retinal slip, or the movement of the image across 
the eye, is within 4 degrees per second. Exceeding this, visual acuity decreases and causes 
blurring or other illusions. While experiencing motion sickness, the ability of the eye to 
compensate for motion can decrease, meaning motion is more likely to exceed the current limits 
of the eye to compensate for retinal slip. A second symptom of motion sickness relating to the 
eye is known as Oscillopsia, or the illusion of movement when remaining stationary. This is 
common of constant motion, occurring when spinning for a period of time long enough for the 
vestibular system to adapt, then stopping. The stabilized vestibular system would now be 
indicating motion despite being stationary and the room may appear to be spinning, which is 
oscillopsia (Leigh, Dell’Osso, Yaniglos, & Thurston, 1988). Both excess retinal slip and 
oscillopsia can be distracting and disorienting symptoms of motion sickness. 
As astronauts adjust to the microgravity environment of low-Earth orbit, they are setting 
up for another period of adaption that will be required upon landing. According to both Black, 
Paloski, Doxey-Gasway and Reschke (1995) and Black et al. (1999), evidence indicates that all 
returning astronauts exhibit a period of postural instability upon landing, generally ranging from 
two to five days. During this time period, astronauts would face clumsiness with movements, 
difficulty walking in a straight line, persisting sensation aftereffects (the feeling of being 
unbalanced), vertigo while walking, vertigo while standing, nausea, difficulty concentrating, and 
vomiting (Bacal, Billica, & Bishop, 2003). Black et al. (1998) found that irregular motion, such 
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as eccentric pitch rotation, disrupted adaptation and could prolong or exacerbate symptoms. 
Generally, both studies found a recovery within 2-4 days, consistent with the expected 2-4 days 
during space adaptation, though extreme cases have lasted as long as 5 days (Black et al., 1998).  
 
Proprioception 
To understand why motion sickness occurs, it is important to understand the 
physiological processes that detect motion in the body. Proprioception is the body’s ability to 
sense where different body parts are located relative to each other. The proprioception system 
can be broken up into the vestibular system, which is designed to detect movement of the head, 
the kinesthetic system, which discerns position, and a visual aspect, the visual cues to 
orientation. These signals from both systems are sent through the visuo-vestibular pathways 
known as the velocity storage mechanism (VSM), where the information is processed and 
compared to provide the interpretation of body position and movement (Ventre-Dominey, Luyat, 
Denise, & Darlot, 2008). In accordance with the Neural Mismatch Theory, a leading theory of 
motion sickness, the discrepancies between the vestibular and kinesthetic inputs are detected by 
the VSM that cause motion sickness symptoms. These discrepancies stimulate the emesis center 
and the chemoreceptor trigger zone (CTZ), and can cause the nausea and vomiting generally 
associated with motion sickness. 
 
Vestibular Systems. The vestibular system is designed to detect the position of the head. 
It is located entirely inside the inner ear and consists of the semicircular canals and the otoliths 
and controls the vestibulo-ocular reflex. Signals from the vestibular system are sent to the 
vestibular nuclei of the brain stem, where they are combined with signals from the visual system 
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and the rest of the proprioception system to establish postural and positional data for the body 
(Lackner, 2004).  
 
Semicircular canals. The three semicircular canals are responsible for discerning 
rotational cues for the brain. Each of the canals is oriented in a different direction to best gather 
rotational information. The horizontal canal, also known as the lateral canal, is located along the 
lateral axis, sensing the rotation of the head left and right. The superior semicircular canal, or the 
anterior canal, is located to sense motion around the rostral-caudal axis, or the tilt of the head, as 
in a nod or leaning the head backwards. The final canal, known as the posterior canal, is 
positioned to detect rotations along the sagittal plane, or the rotation of the face clockwise or 
counterclockwise, as would be done when cocking the head. The canals are shown in Figure 1. 
The canals are full of fluid known as endolymph which, under a stable condition, is unmoving in 
the ear. As soon as motion of the head occurs, the canals and the bony labyrinth move, and the 
endolymph lags behind due to inertia. The difference between the speed of head movement and 
the inertial lag of the endolymph varies with the speed of rotation in the head as well as the 
direction of rotation. As the fluid moves, it passes the ampullae, a location in the canal 
containing the cupula. The cupula in each semicircular canal is held in a neutral location until 
movement adjusts it. 
Hair cells around the cupula sense the movement and transfer the information to the brain 
via the vestibulocochlear nerve (Lackner, 2004). These hair cells are mechanoreceptors that fire 
constantly, regardless of motion. The rate of fire varies depending on the direction and 
magnitude of the motion of the cupula, as seen in Figure 2, increasing the rate of fire when 
moved in one direction, decreasing rate of fire in the other (Buytaert, 2011).  Between each of 
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the three semicircular canals in each inner ear, the vestibular system is able to identify any 
rotational motion of the head or body.  
 
 
Figure 2. Hair cell rate of fire (Buytaert, 2011). 
 
 
Figure 1. The Vestibular System. Note. From Rutka (2004) 
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Otoliths. Like the semicircular canals, the saccule and utricle sense the motion of the 
head, but instead of measuring the rotational motion, they are responsible for measuring the 
linear acceleration, including gravity. The saccule and utricle are oriented to be sensitive to 
different directions of movement. The saccule provides cues to vertical acceleration, like 
standing from a squat, where the utricle is oriented to register horizontal movement (Beule & 
Allum, 2006). Both are also filled with endolymph, just as the semicircular canals are, and also 
contain hair cells. The hair cells in the otoliths are topped with hexagonally shaped calcium 
carbonate crystals known as otoconia. As motion occurs, the inertia otoconia causes the hair cells 
to bend which changes the signals being sent to the VSM (Buyaert, 2011). 
 
Vestibulo-ocular reflex. When the position of the head is adjusted while the eyes are 
focused on an object, the eyes would lose focus if not for an automatic response from the body. 
This response is known as the vestibulo-ocular reflex (VOR). This results from the nerves 
connecting the vestibular system and the brain in communication with nerves that relay 
information to the ocular muscles around the eyes. This provides near-instantaneous 
compensation to the eye, and allows for tracking despite any motion that the head may 
undertake. This is where the primary impact of the VOR on motion sickness stems from. Since 
the human eye is able to continue to track during motion, a person can make out the details that 
will be important in identifying visual cues for motion (Raphan & Cohen, 2002).  
 
Visual Cues. Apparent or illusory motion can cause motion sickness as readily as actual 
motion in many people. This is due to the body’s reliance on visual cues to interpret motion as 
well as the vestibular and kinesthetic inputs. These cues are objects in motion, especially relative 
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to the perceived horizon for motion around 2 planes; the sagittal plane and the rostral-caudal 
plane (Duh, Parker, Phillips, & Fumess 2004). While motion cues, can lead to motion sickness, it 
is not a necessity, as Graybiel (1970) found that visually-impaired persons can still experience 
motion sickness symptoms.  
Kinesthetic system. When well-coordinated adults climb stairs, they have no need to 
watch their feet making each step, yet are still able to climb the stairs quickly without much 
thought. This is because of kinesthesia, or the body’s natural ability to judge how it is oriented 
based upon muscle, tendon, and joint positions. Nerves connecting every muscle, tendon and 
joint in the body send information about these positions to the brain where it is organized into a 
mental picture of how the body is positioned.   Subconsciously using the kinesthetic sense, one 
can perform tasks out of sight, while blindfolded, or without thought due to this sense. This sense 
is also used to differentiate between head motion and body motion; for example, it is used to 
differentiate between tilting your head to the left and your whole body being tilted left. Part of 
this sense is based upon gravity’s pull upon different parts of the body, such as more weight 
being present on one foot due to the whole body tilting in the previous example. Together with 
the vestibular system, this makes up all of the proprioception system; how the body determines 
its position in the environment. 
Organs that make up the kinesthetic system include Golgi tendon organs, muscle 
spindles, and mechanoreceptors located in the skin and joint tissue.  Golgi tendon organs are a 
stretch- and compression-sensitive organs located within muscles throughout the body.  These 
organs react to compressions that occur when a muscle contracts or tightens, and the stretching 
that occurs when a muscle is returned to it lengthened state, sending signals through the afferent 
nerves to the brain, which notes the new position (Prochazka, Gillard, & Bennett, 1997). Muscle 
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spindles are similar to Golgi tendon organs in that they are located within muscles and respond to 
stretching and contracting forces, however they are constantly providing information on their 
position.  They are located within the muscle tissue and are the entire length of the muscle. When 
the muscle contracts or returns to a resting state, the muscle stretches or contracts respectively, 
and alters the signal being sent along a separate afferent neuron to the brain. Due to the muscle 
spindles being a specific length, they can also be used to determine joint position, since the brain 
can interpret which muscles should be stretched or loosened for a joint to be in a particular 
position (Vallbo & Al-Falahe, 1990). The primary mechanoreceptors used in kinesthesis are 
Ruffini and Pacinian corpuscles.  Ruffini corpuscles measure stretching of the skin and tissue 
around joints, and are relatively slow to adapt to the new position, sending signals of their altered 
state for long after the initial change has occurred.  Conversely, Pacinian corpuscles are rapidly 
adapting and are sensitive to touch and vibration.  Due to their location throughout the skin, these 
mechanoreceptors are used in kinesthesis to identify where a body part is located based upon 
what other tissue it is touching (Hagert, Forsgren, & Ljung, 2005).  For example, a brain is able 
to interpret an arm’s position due to the fact that it is touching the side of the chest to the bottom 
of the rib cage.  
These organs are naturally calibrated to working in a 1g gravity environment, and as 
such, when introduced into a microgravity environment, the inputs are weaker, causing a weaker 
or even incorrect signal being sent to the brain.  Stevens & Parsons (2002) indicated that the 
kinesthetic system alone is unable to induce motion sickness, though they also state that it is 
likely that inputs from this system, when in conflict with vestibular or visual signals, can lead to 
or strengthen motion sickness symptoms.  
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Emesis Center and CTZ. The emesis center is responsible for nausea and vomiting. It is 
located in the reticular formation and collects data from the CTZ, a chemoreceptor site located in 
the medulla, in the fourth ventricle. The CTZ receives inputs from the blood in order to collect 
neurotransmitters to excite or inhibit the emesis center. The neurotransmitters that excite the 
emesis center, or agonists, include Histamine, Muscarinic cholinergic, Dopamine, Serotonin (5-
HT3), and Substance P. Substances that counter the agonists, known as antagonists, include 
Promethazine, Atropine, Droperidol, Serotonin (5-HT3) receptor antagonists, and NK-1 receptor 
antagonists. When the CTZ is excited, it sends signals down the neuronal pathways to the emesis 
center, which can cause the emesis center to reach its threshold, which results in nausea and 
vomiting. The receptors on the CTZ can be seen in Figure 3. The emesis center can also be 
excited directly through higher centers, such as vision and taste, the pharynx, and GI tract 
distension (Watcha & White, 1992).  
 
 
 
Figure 3. The Chemoreceptor Trigger Zone and the Emetic Center (Watcha & White, 1992). 
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Motion Sickness Theories 
Though we have an understanding of how the systems important to motion sickness 
work, the differences and variations between people and the near-unpredictable variability of 
symptoms and severity make finding a comprehensive theory that adequately explains the many 
aspects of motion sickness quite elusive.  Therefore, there are several theories that attempt to 
explain how motion affects the human body and causes the symptoms associated with motion 
sickness. Three of the most prevalent theories are Neural Mismatch, Postural Instability, and 
Poison Response. 
 
Neural Mismatch Theory. The most prevalent theory is the Neural Mismatch Theory.  It 
also is known as the Sensory Rearrangement theory and the Sensory Conflict theory.  This theory 
states that motion sickness is caused by a mismatch in signals from the different internal systems 
responsible for identifying the position of the body, proprioception.  These signals give the 
competing information about body orientation in a space, which conflict with one another and 
with signals interpreted during past experiences.  The past experiences, also known as exposure-
history, form the pattern which the body typically uses, namely the natural motion of the body on 
stable land.  
All motion sickness symptoms can be divided into two categories of conflict under the 
Neural Mismatch Theory. These categories are visual-inertial conflict and canal-otolith conflict. 
Visual-inertial conflict occurs when discrepancies exist between the visual system and the 
proprioception systems. Canal-otolith conflict occurs completely within the vestibular system, 
specifically between the semicircular canals determining rotation and the otoliths determining 
head position though gravitational pull (Cobb, Nichols, Ramsey, & Wilson, 1999).  
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Also covered under the Neural Mismatch Theory, three types of sensory conflict can 
occur, known as Type I, II, and III conflicts. A Type I conflict is where two receptors are sending 
information to the brain that either contradicts or fails to correlate with one another. Type II 
conflicts occur when one signal is being received by the brain while another signal that also 
identifies the type of motion occurring with respect to the first signal is missing, in the case of 
motion not occurring but the visual indications of movement, or visual indications but no 
proprioceptive sensation of movement. Type III conflicts occur when the opposite of a Type II 
conflict occurs, or when the physical sensations are present, but the visual indications are telling 
the brain that movement is not occurring (Cobb, Nichols, Ramsey, & Wilson, 1999). 
A key point in the Neural Mismatch Theory is the ability to acquire adaptation to the 
disruption these mixed signals cause. As Reason (1978) states, the theory bases this assumption 
on the ability for seasick sailors to adapt over time, to get their sea-legs back. This is common to 
SAS as well, as susceptible astronauts generally adapt to their environment within the first two to 
four days of the mission.   
 
Postural Instability Theory. A competing theory on the causes of motion sickness 
relates to Postural Instability.  This theory stems from the basis that the human body in action has 
its own natural sway. The body suffers symptoms when the movement of a ship or camel has a 
different sway pattern, or in the case of simulation, virtual reality, and space, a lack of sway. In 
other words, any motion that is contrary to a person’s natural frequency and magnitude of 
movement will cause motion sickness symptoms. One of the main hypotheses of this theory 
states that the intensity of the motion sickness symptoms is directly proportional to the intensity 
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of the magnitude of the conflicting frequency (Warwick-Evans, Symons, Fitch, & Burrows, 
1998). 
 
Poison Response Theory. A third explanation for the causes of motion sickness is the 
Poison Response Theory. Unlike the other two, this theory states that the signals being sent to the 
brain are not the cause of motion sickness, but rather the use of the body’s reflex response to 
poisoning that cause the symptoms.  The assumption is that the brain interprets the different, 
confusing sensory inputs motion disruption causes as indicators that they body is being poisoned 
and takes action.  Evidence has shown that the vestibular system may act as a secondary 
mechanism to the chemoreceptors, sending a signal to the CTZ for the body’s poison response to 
occur (Hershkovitz, Asna, Shupak, Kaminski, & Bar, 2009).  The Poison Response theory relies 
on two primary components: stomach emptying and stress response. Alkalosis, or the heightened 
pH of blood, can be caused by a loss of hydrogen ions, and can cause vomiting and stress 
symptoms such as those associated with motion sickness. This hydrogen ion loss can be 
associated to dissolving carbon dioxide into the fluids of the stomach during rapid churning, 
causing carbonic acid, which attracts hydrogen ions.  Sodium loss through perspiration and the 
release of antidiuretic hormones can also cause similar symptoms. This theory provides 
explanation that fills some of the holes in the Neural Mismatch and the Postural Instability 
theories (Lackner, 2004). 
Each of these three theories explains a different aspect of what causes motion sickness, 
though none of these theories are comprehensive. Warwick-Evans et al. (1998) performed a 
study designed to evaluate the Postural Instability theory and compare it with the Neural 
Mismatch theory and found more evidence supporting the Neural Mismatch Theory. 
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Specifically, they found that a reduction in the impacts of postural instability does not directly 
relate to the reduction of motion sickness symptoms, thus presenting a strong case that the 
Neural Mismatch Theory better describes the theory behind motion sickness. Critics of the 
Poison Response theory state that subjects lacking a functioning vestibular system do not 
experience motion sickness, but proponents of the theory state that experimental animals are less 
sensitive to drugs that induce vomiting following the removal of the entire vestibular system 
(Lackner, 2004). There is therefore no theory that adequately covers every aspect of motion 
sickness, and this leads to a difficulty in the predictability of motion sickness symptoms. In the 
future, a comprehensive theory may be established and would certainly include many aspects of 
the individual theories just discussed.  
 
Measurements 
Though the exact theory of motion sickness is unclear, how the many symptoms are 
measured, including disorientation and nausea is well-documented. To gauge the effectiveness of 
countermeasures, researchers quantify symptoms. This section covers a portion of the techniques 
used to quantify these symptoms, concentrating on ones which will be used in this study. These 
techniques can be classified as subjective measures, measures of fatigue, cognitive, and 
biochemical measures.  
 
Subjective. Subjective measurements are among the most commonly used when 
researching. They are relatively easy to acquire and can put numbers to aspects that are difficult 
to evaluate otherwise. For some aspects, subjective measurements can be the only source of data. 
One of the drawbacks of subjective measurements though, stems from the lack of quantifiable 
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data from the measurements. For example, if a subjective measure is asking for nausea on a scale 
of one to ten, one being low feeling, ten being high, each participant will have a different belief 
of what each number in the range represents, leading one participant to mark “6” while a 
different participant might mark “4” for the same level of the symptom. Another common 
drawback of subjective measures stems from pride in participants, especially when studying 
fatigue. Many participants, in an attempt to show how tough they are, will refuse to admit they 
are tired, sore, or sick. This is usually combated by testing individually, in an environment where 
the participant doesn’t feel the need to show off for anyone. A third drawback was illustrated by 
Young, Adelstien, and Ellis (2007), when they found that administering a pre-test questionnaire 
made it significantly more likely for participants to suffer from symptoms. Three subjective 
measures that will be utilized in this study are the Motion Sickness Susceptibility Questionnaire 
(MSSQ), the Simulator Sickness Questionnaire (SSQ), and the Stanford Sleepiness Scale (SSS).  
 The MSSQ was designed in 1991 in an attempt to predict the susceptibility of a 
participant to motion sickness symptoms. Participants using this questionnaire self-rate 
themselves in 12 situation based upon past experiences with motion sickness, then 2 questions on 
how they feel they experience symptoms compared to others, and finally 2 questions about any 
past or present health concerns.  Results are analyzed and compared to the results of participants 
from previous studies using the test (Griffin & Howarth, 2000). 
In order to get an accurate representation of motion sickness symptoms, many 
questionnaires have been developed.  The Pensacola Motion Sickness Questionnaire (MSQ) was 
a popular prior to the early 1990’s, though some concerns led to it becoming less commonly 
used. One major concern of the MSQ was the sensitivity of the tests used to develop it. These 
tests consisted of stimuli that would likely produce vomiting, or come close to it. Kennedy et al. 
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(1993) found low sensitivity to early symptoms of motion sickness, requiring more severe 
stimuli that scientists were using to identify motion sickness was occurring.  
One such questionnaire that has become common in recent studies has been the Simulator 
Sickness Questionnaire (SSQ) developed by Kennedy et al. (1993). The SSQ was derived from 
the MSQ, with the full SSQ asking for the same 30 symptoms the original MSQ asked from 
participants, though only 16 are scored. This self-answered questionnaire is presented to 
participants in motion sickness studies and allows for a four point (0-3) scale, 0 being no 
symptoms and 3 being severe. The 16 scored symptoms of the Simulator Sickness Questionnaire 
were divided into three symptom clusters based upon a factor analysis: Oculomotor, 
Disorientation, and Nausea. In these clusters of Kennedy et al. (1993) include eyestrain, 
difficulty focusing, blurred vision, and headache in the oculomotor cluster, dizziness with eyes 
open or closed, and vertigo in the disorientation cluster, and increased salivation, stomach 
awareness, and burping fall into the nausea cluster. General discomfort, fatigue, sweating, 
nausea, fullness of head, and difficulty concentrating were identified as symptoms, but did not fit 
into any of the three clusters though are no less important. Other potential symptoms were 
considered and reviewed, but were ultimately ruled out due to the lack of frequency or 
occurrences with other identified symptoms (Kennedy et al., 1993). 
The SSQ has been identified as an accurate method of classifying motion sickness 
symptoms well beyond just simulator sickness, including many other forms of motion sickness. 
Both Palmisano, Bonato, Bubka, and Folder (2007) and Bubka, Bonato, Urmey and Myceqicz 
(2006) showed the SSQ was successful in capturing motion sickness symptoms when 
participants were exposed to vection. The SSQ was expected to fulfill the needs of this study. 
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Fatigue. As discussed earlier, Sopite Syndrome will occasionally be the only symptom 
someone sensitive to motion sickness will suffer from. To ensure that all participants suffering 
from the effects of motion sickness are identified, it is important to measure this induced fatigue 
as well. The SSS is a simple subjective measure for identifying fatigue, and was used in this 
study. It used a simple 7 point self-testing scale with definitions specific to each level to measure 
sleepiness. The specific definitions for each level help to eliminate some of the variability 
between participant responses at the same level of alertness (Hoddes, Zarcone, Smythe, Phillips, 
& Dement, 1973). Participants selected the level that best applies to them. This data was used to 
identify fatigue and to check for Sopite. 
 
Cognitive Test. Yet another measure that was used in this study was the Switching Test. 
This test, which was made up of one section of the much larger Automated Neuropsychological 
Assessment Metrics (ANAM) test, evaluates mental flexibility and shifting. The three parts of 
this dual test section were the Manikin test and the Mathematical Processing Task, with a third 
task requiring attention to a cue that tells the participant when to move between tests. The 
Manikin test shows images of a human suspended in different directions, forward, backwards, 
upside-down, with an object in either outstretched hand. The participant must identify which of 
the human’s hands a particular object is in. This is usually considered a test of spatial reasoning. 
The Mathematical Processing Task presents a series of simple mathematical equations in the 
format of (X+Y-Z=?). In this task, each of X, Y, Z, and the result are numbers between 1 and 9, 
though the answer is never 5, where each number is equally probable in any position except 5. 
The Switching test can be administered in multiple ways, including both Manikin and 
Mathematical Processing on the same screen with an arrow pointing to one another to identify 
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which question to answer or only one on the screen at a time alternating randomly between 
Manikin and Mathematical Processing (Reeves, Winter, Bleiberg, & Kane, 2007). The results of 
this test indicate and predict any cognitive impairment as a result of motion sickness. 
 
Balance. Balance is often cited as a symptom of motion sickness, therefore two balance 
tests were given as part of this study. The first was a heel-to-toe test, in which participants 
walked a straight line for 7 steps, heel-to-toe, turned on the balls of their feet, and then returned 
along the line an additional 7 steps. Both completion time and missed steps were recorded.  
The second balance test was an adapted Finger-to-nose test (FTNT), where the 
participant closed their eyes, stand with one foot approximately twelve inches above the ground, 
and extend both arms horizontally. Then the participant was instructed to bring their middle 
finger tip to their nose with one hand, return it to the original extended position, and repeat with 
the other hand. The number of times the participant either lowered their raised foot or needed 
assistance in balancing was recorded.  
 
Biochemical. Endocrine measures can provide strong insight into motion sickness as 
well. Cortisol is a hormone released by the adrenal gland that can be easily collected in saliva 
samples. It has been identified as an indicator of stress levels.  Chouker et al. (2010) found a 
significant correlation between the increasing intensity of motion sickness and increasing cortisol 
levels. Comparing cortisol levels in participants following vection induced motion sickness to 
levels prior should provide another objective indication of motion sickness.  
Norepinephrine (NE) is another biochemical indicator of that is useful in objectively 
identifying symptoms associated with motion sickness. Specifically, NE is an indicant of stress 
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and has evidence that it may be even more sensitive an indicator than blood pressure or heart rate 
to stress (Aragaki, Etoh, Hojo, Takaj, & Nishikawa, 2003; Chatterton, Vogelsong, Ellman, Lu, & 
Hudgens, 1996). It is possible that, combined with indications from other biochemical markers, 
NE would provide an objective indication of motion sickness. NE can be tracked through 
salivary amylase (Skosnik, Chatterton, Swisher & Park, 2000). 
Countermeasures 
 Countermeasures for motion sickness have been around since the early days of boat and 
camel travel. Many countermeasures have scientific backing, while others are pure fable. 
Countermeasures can be divided between two major categories: Pharmacological 
countermeasures and behavioral countermeasures. Both methods have their benefits and 
drawbacks, but both can be applied to motion sickness symptoms and provide varying results 
and side effects in combating SAS. 
 
Pharmacological.  Many different pharmacological countermeasures have been 
developed for quelling motion sickness symptoms. Many have successful application on Earth 
that would not be suitable for use in space due to unwanted side effects. As seen in Table 1, 
many pharmacological countermeasures have one common side effect, drowsiness. This can be a 
dangerous symptom when paired with fatigue stemming from motion sickness already, 
especially in an emergency situation. Extrapyramidal side effects (EPSE), such as the inability to 
move, akinesia, or the inability to remain stationary, akathesis, can be just as deadly. If an 
astronaut were suffering for symptoms like drowsiness, lack of concentration, vertigo, or EPSE, 
he or she might not be able to adequately complete checklist items, follow through with 
emergency procedures, or even identify that an emergency is occurring which requires his or her 
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attention. Until a pharmacological countermeasure that does not subject users to side effects such 
as these are identified, another solution to motion sickness symptoms must be found. 
 
 
Table 1. Common pharmacological countermeasures to motion sickness, their success, and side 
effects,  
Pharmaceutical Type Effectiveness Side Effects 
Dramamine  H1 Antihistamine 
/Muscarinic 
antagonist 
Some
3
 Drowsiness
3
 
Chlorpheniramine H1 Antihistamine Effective
2
 Drowsiness, Lack of Concentration, 
indigestion
2
 
Scopolamine 
(Hyoscine) 
Anti-cholinergic “great 
success,”1 
Effective in 
adaptation
2
 
Dry mouth, drowsiness, mydriasis  
(pupil dilation)
1
 
Promethazine Anti-cholinergic  “great 
success”1 
Drowsiness, vertigo, constipation, Dry 
mouth, impaired alertness
1
  
Ondansetron/ 
Ramosetron 
5HT3 Receptor 
Antagonist 
Subjectively 
considered 
ineffective
2, 4
 
Headache, thirst, constipation, diarrhea, 
fever, EPSE (akinesia and muscle 
spasms)
5
 
Note. From 
1
(Lackner & DiZio, 2006),
 2
(Takeda et al., 1993), 
3
(Weinstein & Stern, 1997), 
4
(Hershkovitz et al., 2009), 
5
(Shi et al., 2007) 
 
 
Behavioral. Behavioral countermeasures have been in use nearly as long as motion 
sickness has been an issue. They have the general benefit of always being available, despite 
mixed effectiveness between people.  Behavioral countermeasures can be into between two 
different types: in situ and pre-exposure training. 
  
In situ. In situ countermeasures, or countermeasure performed while motion sickness is 
occurring, have varying effectiveness on Earth. In space, many of these same countermeasures 
are much less effective than on the ground. Yen Pik Sang, Billar, Golding and Gresty (2003) 
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found that controlled breathing and listening to calming music delayed the onset of motion 
sickness, though did nothing to prevent or lessen symptoms of motion sickness when sickness 
eventually occurred. This follows similar research that indicates that most behavioral 
countermeasures used on Earth do little to nothing for astronauts facing SAS. The theory behind 
this result is on Earth, these countermeasures can end the sensory conflict, whereas in space, the 
conflict will continue to persist until the environment is left. Adaption time and symptom 
severity have been shown to relate to the behavioral activities of astronauts experiencing the 
symptoms. Lackner and DiZio (2006) found that excessive head motion or orientation different 
to that of other astronauts on the space station would increase SAS symptoms and extend 
adaptation time of astronauts during the first days of their mission. Therefore, extrapolating from 
those results, avoiding rapid head movements or abnormal orientation in comparison to other 
astronauts should be effective in decreasing the length of time SAS impacts an astronaut. 
 
 Pre-Exposure Training. While little can be done in the environment to decrease the 
symptom severity and adaptation time of an astronaut currently experiencing motion sickness, 
studies have examined the possibility of increasing adaptability prior to reaching the 
microgravity environment. One such method of decreasing the symptoms associated with motion 
sickness that has shown to be effective is pre-exposure training. The usefulness of pre-exposure 
training stems from the learning aspect of the Neural Mismatch Theory which states that it is 
possible to acquire resistance to the type of motion sickness being presented. Continuing to build 
off the aspects of this theory, motion sicknesses of the same type should react the same way to 
pre-exposure.  
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Smither et al. (2008) found positive results for participants receiving training via self-
propelled rotation simulation on symptoms caused by OKD and a virtual reality device 24 hours 
after the last training session. Similar results were found by Clement et al. (2001) when 
comparing cosmonaut vestibular training to rotating chair motion sickness exposure. 
Pre-exposure training has never been adequately tested prior to an actual space launch. 
As stated by Clement et al. (2001), the expense of testing the hypothesis of the training effects on 
SAS, however the earthbound results are promising, and the in situ experiments are not 
significantly effective. Therefore, it would seem that the most likely countermeasure for SAS in 
the future would be pre-exposure training. 
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Method 
Participants 
 Participants were recruited through advertising in the college newspaper and flyers 
posted around campus. All participants were compensated monetarily for their time. There were 
a total of 27 university students who participated in this study ranging from 18-24, all of whom 
were tested to ensure susceptibility to motion sickness through the use of the 75% threshold of 
the MSSQ (Appendix A). The participants were randomly divided into 3 groups. Group 1 and 2 
received the self-induced Coriolis pre-exposure training. Group 1 was exposed to the OKD 6 
hours after the completion of the last training session, while group 2 was exposed to the OKD 24 
hours after the completion of the last training session. Group 3 received no training prior to OKD 
exposure.  
 
Materials and Apparatus 
 The study was conducted in two different rooms in accordance with experimenter (single) 
blind procedures. Pre-exposure training occurred in one room administered by one person, while 
the OKD exposure occurred in a second room administered by a second person. Standard office 
conditions were used for both rooms. 
 Optokinetic exposures occurred in the OKD constructed at Embry-Riddle Aeronautical 
University. This drum has been used to successfully induce motion sickness in the past. The 
device consists of a 1.6 meter tall drum with a radius of 2.1 meters, which can be rotated with a 
motor attached to the center of the device. A stationary chair set at a viewing distance of 60 
centimeters from the drum allowed participants to be seated during the experiment for both 
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safety and control. The drum is covered in a curtain that has a pattern that provides an indication 
of motion when the drum is spinning. The signal mismatch between visually perceived motion 
due to the drum spinning and lack of physically perceived motion due to remaining stationary 
provides a sensory conflict, inducing motion sickness. An example of a participant seated in an 
OKD can be seen in Figure4, though the pictured drum is much smaller than the one being used 
in the present study. This study will be making use of a sandpaper-like pattern, which can be 
seen in Figure 5. 
 
 
 
Figure 4. An Optokinetic Drum (OKD) in operation. Note. The actual drum is not transparent. 
 
 
Measurements were conducted in a single test battery one prior to and twice following 
OKD exposure. The tests that will be administered were the SSQ, the SSS, the switching test, the 
balance tests, and the biochemical amylase collection. 
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Figure 5. Sandpaper pattern used in the OKD 
 
 
 The SSQ was given verbally, with the researcher recording the results on paper. The SSS 
was given in paper form. Results were compared to the participants’ initial responses to 
determine the effect of the OKD, then compared with the other participants to discern the effect 
of the primary hypothesis. Multiple Friedman and Mann-Whitney U tests were conducted to 
compare the results.  
 The Switching test was administered on USB drives to participants. A copy of the 
switching test was given to participants one week prior to OKD exposure, and participants were 
expected to consistently reach a score over 90% prior to testing. Data collected from this test 
were accuracy and mean reaction time, as well as a correlation between the two. The results were 
statistically analyzed for significance. 
The saliva to be tested for cortisol and alpha-amylase were collected during the test 
battery prior to and following OKD exposure. The collected saliva were sent for biochemical 
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assay to a commercial facility, Salimetrics, LLC., to analyze for cortisol. These samples were 
collected by the Salimetrics Passive Drool tool and frozen until shipping. 
Two methods of testing a participant’s balance were used. A heel-to-toe line walk 
measured the length of time required to complete 14 steps and a turn, and an adapted FTNT was 
used to identify how many times a participant was required to use exterior support while 
attempting a moving balance test. 
 
Experimental Design 
 The experiment was conducted to study three aspects of motion sickness. The study was 
separated into two between-groups designs and one within-subject experimental design. 
Study 1.  Analyze the effect of pre-exposure training on motion sickness symptoms 
Study 2. Analyze the effect of a shorter time delay between pre-exposure training and a 
stronger stimulus has on motion sickness symptom strengths rather than a longer delay. 
Study 3. Analyze the efficacy of measuring melatonin, cortisol and alpha-amylase to 
ascertain the occurrence of motion sickness. 
 
Independent variables. There were two independent variables for this study. The first 
independent variable was experiencing pre-exposure training or not. The second independent 
variable was the length of time between the last training session and exposure to the OKD.  
 
Dependent measures. The dependent measures for this study were: (1) salivary Cortisol 
level, (2) salivary alpha-amylase level, (3) missed balance steps, (4) heel-to-toe balance time, (5) 
FTNT score, (6) motion sickness symptoms, (7) fatigue level, and (8) cognitive performance.  
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Procedure 
After signing an informed consent form (Appendix B) and completing a demographics 
form (Appendix C), participants took a Motion Sickness Susceptibility Questionnaire (MSSQ).  
Using the MSSQ, the researcher ensured that all participants are sensitive to motion at the 75% 
threshold based upon past data (Griffin & Howarth, 2000).  Groups 1 and 2 were given the pre-
exposure training, while for group 3 did not. The pre-training consisted of self-induced Coriolis 
training for 30 seconds at a time, five times over 2 hours each of 4 days. Participants were asked 
to raise their left arm straight up, grab their left ear with their right arm, and bend 90 degrees at 
their waist in order to put their proprioceptive senses in an abnormal position while spinning. 
Participants rotated themselves 10 times in 30 seconds, rotating at 20 revolutions per minute. The 
SSQ were administered following each day of training.  Following the last day of training each 
week for Groups 1 and 2, or in the first session for Group 3, participants were exposed to vection 
induced motion sickness in the OKD. During OKD exposure, the SSQ was administered every 5 
minutes by a recorded message, with the researcher marking the verbal results for the participant 
on paper.  
Following OKD exposure, a series of tests occurred. This test battery began with the 
Simulator Sickness Questionnaire (SSQ) (Appendix D) and the SSS (Appendix E). The SSQ has 
been developed and proven effective at quantifying the symptoms of motion sickness (Kennedy 
et al., 1993). Tiredness of participants was measured through the Stanford Sleepiness Scale 
(SSS). Following the SSQ and SSS, a 5-minute cognitive test, known as a switching test, was  
given to assess cognitive effects of the OKD exposure. Instructions given to participants are 
located in Appendix F.  Neuroendocrine measures identified stress and motion sickness through 
saliva samples, one taken for a baseline prior to OKD exposure, one immediately after each 
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cognitive test following OKD exposure. This test battery was administered immediately 
following OKD exposure and a second time 30 minutes following OKD exposure.  
 
Handling of motion sickness symptoms in the laboratory. Throughout the study, the 
researcher kept air sickness bags, cleaning products including bleach, gloves, and light snacks 
readily available. No participants vomited during this study. For their safety, all participants were 
required to remain in the laboratory until they no longer show motion sickness symptoms on the 
SSQ, and no less than 30 minutes following the end of their OKD exposure.  
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Results 
The present study was designed to identify the ability of the OKD to cause motion 
sickness in participants and to determine if the measures used were sensitive enough to capture 
differences between groups. Twenty-seven participants were selected to participate in this study, 
16 female and 11 male. Only participants who exceeded the 75th percentile of the MSSQ were 
selected to participants. Participants were randomly divided into 3 groups; Group 1 (PT06) 
received the mild pre-exposure training and were exposed to the more severe motion sickness 
inducing event (the OKD) 6 hours after their last training session, Group 2 (PT24) received the 
mild pre-exposure training and were exposed to the OKD event 24 hours after their last training 
session, and Group 3 (NT) did not receive pre-exposure training and were only exposed to the 
OKD.  
 
Effect of OKD Exposure 
SSQ Total Score. A Friedman test was conducted to compare the effect of OKD 
exposure on SSQ Total (SSQT) score. A significant effect was found on SSQT score on the 
combined groups, 2(3, 27) = 69.172, p < 0.001. A Wilcoxon Signed Ranks test was conducted 
to further investigate the effect of OKD exposure on SSQ Total score. The results of this test 
indicated that within all groups, higher SSQT scores were collected 10 minutes into OKD 
exposure than the baseline pre-test, Z = 4.542, p < 0.001. The results of this Wilcoxon Signed 
Ranks test also indicated that within all groups, higher SSQT scores were collected 20 minutes 
into OKD exposure than the baseline pre-test, Z = 4.543, p < 0.001.  The results of this Wilcoxon 
Signed Ranks test also indicated that within all groups, higher SSQT scores were collected 30 
minutes into OKD exposure than the baseline pre-test, Z = 4.543, p < 0.001.  The results of this 
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Wilcoxon Signed Ranks test also indicates that within all groups, higher SSQT scores were 
collected 20 minutes into OKD exposure than 10 minutes into OKD exposure, Z = 3.930, p < 
0.001. The results of this Wilcoxon Signed Ranks test also indicated that within all groups, 
higher SSQT scores were collected 30 minutes into OKD exposure than 10 minutes into OKD 
exposure, Z = 3.844, p < 0.001. The results of this Wilcoxon Signed Ranks test also indicated 
that within all groups, higher SSQT scores were collected 30 minutes into OKD exposure than 
20 minutes into OKD exposure, Z = 3.229, p < 0.001. These results indicated that exposure to 
the OKD can induce motion sickness symptoms. They also indicated that the longer the time 
spent in the OKD, the more intense the OKD symptoms. This trend can be seen in figure 6.  
 
 
 
Figure 6. SSQ Total Scores between groups, with SSQ Total score on the vertical axis and time 
relative to initial OKD exposure on the horizontal axis. The time = 0 point represents the pre-test. 
A difference exists between the NT group and both PT groups at the 35 and 65 minute marks. 
Asterisks indicate the presence of a significant difference, and are in the color corresponding to 
the group that is different with. Error bars indicate quartiles.  
 
0
40
80
120
160
200
0 10 20 30 35 65
Sc
o
re
 
Time (minutes) 
SSQ Total 
PT24
PT06
NT
Post-
Vection 
38 
 
 
 
Cortisol. A repeated measures analysis of variance (ANOVA) was conducted to compare 
the effect of OKD exposure on salivary cortisol level. The results of the test indicated that there 
was a difference in cortisol levels due to OKD exposure, F (2, 72) = 6.957, p < .01. A Tukey 
HSD post hoc test was conducted between the different test intervals to further analyze the effect 
of OKD exposure on salivary cortisol levels. The results of the test indicated a higher cortisol 
levels during 30 minutes following exposure (M = .433, SD = .38) than the levels prior to 
exposure(M = .1597, SD = .13), and higher levels in 30 minutes following exposure than 
immediately following exposure(M = .2739, SD = ..22), but showed no difference between 
cortisol levels sampled immediately following exposure and levels sampled prior to OKD 
exposure. These results indicated that salivary cortisol may take longer to indicate symptoms of 
motion sickness that other measures used in this study, but does identify the occurrence of 
motion sickness symptoms due to exposure to the OKD. The increasing trend can be seen in 
Figure 7. 
 
Stanford Sleepiness Scale (SSS).  A Friedman test was conducted to compare the effect 
of OKD exposure on SSS score. The results of the test indicated that a difference was found in 
SSS scores due to OKD exposure, 2(2, 27) = 29.370, p <.01. Wilcoxon Signed Ranks tests were 
conducted to further analyze this difference. The results of the test indicate that SSS score were 
higher immediately following OKD exposure than those collected prior to OKD exposure, Z (26) 
= -4.173, p < .01, the SSS score were higher 30 minutes following OKD exposure than those 
prior to OKD exposure, Z (26) = -2.784, p < .01, and higher immediately following OKD 
exposure than 30 minutes following OKD exposure, Z (26) = -3.753, p < .01. This indicates that  
 
39 
 
 
 
 
Figure 7. Salivary Cortisol levels between groups, with cortisol level in ml/dl on the vertical axis 
and time relative to OKD exposure on the horizontal axis. . The time = 0 point represents the pre-
test. A difference exists between the 0 and 35 minute time intervals and the 0 and 65 minute time 
intervals, but not between the 35 and 65 minute time intervals. 
 
 
motion sickness symptoms related to disorientation were identified by participants following 
OKD exposure and partial recovery occurred within 30 minutes, as can be seen on Figure 8. 
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Figure 8. SSS Scores between groups, with SSS Score on the vertical axis and time relative to 
OKD exposure on the horizontal axis. . The time = 0 point represents the pre-test. A difference 
exists between the 0 and 35 minute time intervals, the 0 and 65 minute time intervals, and the 35 
and 65 minute time intervals. Error bars are quartiles for each group. 
 
 
FTNT test score. An ANOVA was conducted to compare the effect of OKD exposure on 
FTNT test score. The results of the test indicated a difference between FTNT test scores as a 
result of OKD exposure, F (2, 72) = 3.527, p =.035. A Tukey HSD post hoc test was conducted 
to further analyze the results. The results indicated higher FTNT test scores immediately 
following OKD exposure (M = .6296, SD = .96) than prior to OKD exposure (M = .2222, SD = 
.42). The result of the tests also showed no difference between FTNT scores immediately 
following OKD exposure and those 30 minutes following OKD exposure (M = .3333, SD = .55), 
or 30 minutes following OKD exposure and prior to OKD exposure. This indicates that the 
FTNT test may capture the onset of motion sickness symptoms accurately, though symptoms of 
motion sickness that cause a decrease in performance on the FTNT test may take longer than 30 
minutes to recover from. This trend can be seen in Figure 9.   
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Figure 9. FTNT test score between groups with FTNT score on the vertical axis and time relative 
to OKD exposure on the horizontal axis. The time = 0 point represents the pre-test. A difference 
exists between the 0 and 35 minute time intervals, and the 0 and 65 minute time intervals, but not 
the 35 and 65 minute time intervals. Error bars are in standard deviation for each group. 
 
 
Alpha Amylase. An ANOVA was conducted to compare the effect of OKD exposure on 
salivary amylase level. The results of the test showed no difference between salivary amylase 
levels exists, F (2, 72) = 2.861, p = .064. This indicates that salivary amylase did not indicate the 
occurrence of motion sickness symptoms during this study. It should be noted that participant 
amylase level varied greatly, which can be seen with the standard deviation bars in Figure 10.  
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Figure 10. Salivary amylase levels between groups, with amylase level in U/minute on the 
vertical axis and time relative to OKD exposure on the horizontal axis. . The time = 0 point 
represents the pre-test. No differences between times were shown.  
 
 
Heel-to-Toe test time. An ANOVA was conducted to compare the effect of OKD 
exposure on heel-to-toe balance test time. The results of this test showed no difference existed on 
heel-to-toe balance test time due to OKD exposure, F (2, 72) = 1.465, p =.238. The results 
indicate that heel-to-toe balance times were not likely affected by OKD exposure. 
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Switching test accuracy. An ANOVA was conducted to compare the effects of OKD 
exposure on ANAM Switching test accuracy. The results of the test showed no difference existed 
in Switching test accuracy due to OKD exposure, F (2, 72) = 1.559, p = .217.This indicates 
switching test accuracy was not impacted by the onset of motion sickness. 
 
Switching test time. An ANOVA was conducted to compare the effect of OKD exposure 
on Switching test response time. The results of the test showed no difference between Switching 
test response time due to OKD exposure, F (2, 72) = 2.162, p = .122. These results indicate that 
the ANAM Switching test time did not identify the onset of motion sickness symptoms.   
 
Effect of Pre-Exposure Training 
The median scores for each of the SSQ tests are reported for the combined groups in 
Tables 2. This table also shows median SSQ scores are much higher for the immediately post 
OKD as compared to the scores 30 minutes following OKD. Medians for SSQ Nausea and 
Oculomotor score immediately following OKD exposure are not shown in the Table 2 as no 
significant difference was found.  
 
SSQ Total score. A Kruskal-Wallis test was conducted to compare the effect of pre-
exposure training on SSQ Total score during OKD exposure. The results of the test showed that 
there was no difference between groups during the pretest, 2(2, 27) = 1.064, p = 0.59, no 
difference between groups 10 minutes into OKD exposure, 2(2, 27) = 0.519, p = 0.77, no 
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Table 2. Descriptive Statistics for identifying the effect of pre-exposure training on SSQ tests 
 
Measure N 
Median Immediately 
Following OKD 
Median 30 Minutes 
Following OKD 
SSQ Total Score  27 115.9 37.4 
SSQ Nausea Score 27 -* 28.6 
SSQ Oculomotor Score 27 -* 75.8 
SSQ Disorientation 27 153.12 41.76 
*Only significant results shown. 
 
 
difference was shown between groups 20 minutes into OKD exposure, 2(2, 27) = 1.253, p = 
0.53, and no difference was shown between groups 30 minutes into OKD exposure, 2(2, 27) = 
2.749, p = 0.253. These results indicate that there was no difference in the onset of symptoms in 
the OKD regardless of the presence or absence of pre-exposure training.  
A Kruskal-Wallis test was conducted to compare the effect of pre-exposure training on 
SSQ total score following exposure on all groups. A significant effect was found on SSQ total 
score taken from participants immediately after exposure, 2(3) = 6.409, p = 0.041, and 30 
minutes after exposure, 2(3) = 9.092, p = .011. A Mann-Whitney test was conducted to test the 
hypothesis that pre-exposure training that concluded 6 hours prior to OKD exposure would 
decrease self-reported motion sickness symptoms immediately following OKD exposure as 
compared to participants who did not receive training. The results of the test indicated that, 
immediately following exposure, the 6 hours after training group had less self-rated motion 
sickness symptoms (Mdn = 86.02) than the no training group (Mdn = 134.64), U  = 11.5, p = 
.008. A power of .73 was calculated for this comparison. A nonparametric effect size estimator 
indicated that a 14.2% chance exists that a participant randomly selected from the 6 hour after 
45 
 
 
 
training group would have higher motion sickness symptoms than a participant randomly 
selected from the no training group. A Mann-Whitney test was conducted to test the hypothesis 
that pre-exposure training that concluded 6 hours prior to OKD exposure would decrease self-
reported motion sickness symptoms 30 minute following OKD exposure as compared to 
participants who did not receive training. The results of the test indicated that 30 minutes 
following exposure, the 6 hours after training group had less self-rated motion sickness 
symptoms (Mdn = 26.18) than the no training group (Mdn = 82.28), U = 11.0, p < 0.01. A power 
of .77 was calculated for this comparison. A nonparametric effect size estimator indicated that a 
13.6% chance exists that a participant randomly selected from the 6 hour after training group 
would have higher motion sickness symptoms than a participant randomly selected from the no 
training group.   
A Mann-Whitney test was conducted to test the hypothesis that pre-exposure training that 
concluded 24 hours prior to OKD exposure would decrease self-reported motion sickness 
symptoms immediately following OKD exposure as compared to participants who did not 
receive training. The results of the test indicated that the 24 hour after training group did not 
have less self-rated motion sickness symptoms (Mdn = 104.72) than the no training group (Mdn 
= 134.64) immediately after training, U = 22.50, p = 0.113. A power of .45 was calculated for 
this comparison. A nonparametric effect size estimator indicated that a 27.8% chance exists that 
a participant randomly selected from the 24 hour after training group would have higher motion 
sickness symptoms than a participant randomly selected from the no training group. A Mann-
Whitney test was conducted to test the hypothesis that pre-exposure training that concluded 24 
hours prior to OKD exposure would decrease self-reported motion sickness symptoms 30 
minutes following OKD exposure as compared to participants who did not receive training. The 
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results of the indicated that the 24 hour after training group had less self-rated motion sickness 
symptoms (Mdn = 26.18) than the no training group (Mdn = 82.28) 30 minutes following 
exposure, U = 11.5, p = 0.008. A power of .35 was calculated for this comparison. A 
nonparametric effect size estimator indicated that a 14.2% chance exists that a participant 
randomly selected from the 24 hour after training group would have higher motion sickness 
symptoms than a participant randomly selected from the no training group.  
Comparing the 6 hour after training group with the 24 hour after training group, a Mann-
Whitney test was conducted to test the hypothesis that pre-exposure training that concluded 6 
hours prior to OKD exposure would decrease self-reported motion sickness symptoms 
immediately following OKD exposure as compared to participants who concluded pre-exposure 
training 24 hours prior to OKD exposure. The results of the test indicated that self-rated motion 
sickness symptoms for the 6 hour after training group (Mdn = 86.02) were no different than the 
self-rated symptoms of the 24 hour after training group (Mdn = 104.72) immediately after 
exposure, U = 33.5, p = 0.546. A nonparametric effect size estimator indicated that a 41.4% 
chance exists that a participant randomly selected from the 6 hour after training group would 
have higher motion sickness symptoms than a participant randomly selected from the 24 hour 
after training group. A Mann-Whitney test was conducted to test the hypothesis that pre-
exposure training that concluded 6 hours prior to OKD exposure would decrease self-reported 
motion sickness symptoms 30 minutes following OKD exposure as compared to participants 
who concluded pre-exposure training 24 hours prior to OKD exposure. The results of the test 
indicated that self-rated motion sickness symptoms for the 6 hour after training group (Mdn = 
26.18) were no different than the self-rated symptoms of the 24 hour after training group (Mdn = 
26.18) 30 minutes after exposure, U = 38.5, p = 0.863. A nonparametric effect size estimator 
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indicated that a 47.5% chance exists that a participant randomly selected from the 6 hour after 
training group would have higher motion sickness symptoms than a participant randomly 
selected from the 24 hour after training group.  
These results indicated that pre-exposure training can decrease the time required to 
recover from symptoms of motion sickness, and that exposure 6 hours prior to the more extreme 
motion sickness inducing event may decrease the peak symptoms of motion sickness. The results 
indicated self-rated symptom recovery benefitted from pre-exposure training regardless of the 
time between the pre-exposure training and the more extreme motion sickness environment. This 
trend can be seen above in Figure 6.  
SSQ Nausea score. A Kruskal-Wallis was conducted to compare the effect of pre-
exposure training on SSQ Nausea score following OKD exposure. The results of the test 
revealed difference in SSQ Nausea scores immediately after exposure, 2(3) = 4.467, p = 0.107.  
A Kruskal-Wallis test was conducted to compare the effect of pre-exposure training on 
SSQ Nausea score. The results of the test indicated a difference in SSQ Nausea score 30 minutes 
after exposure, (2(3) = 9.835, p < 0.01). A Mann-Whitney test was conducted to further analyze 
the difference indicated by the previous test. The results of this test indicated that participants in 
the 6 hour after training group had less self-rated motion sickness symptoms related to nausea 
(Mdn = 9.54) and the no training group (Mdn = 57.24) 30 minutes following exposure U = 7.0, p 
< 0.01. A nonparametric effect size estimator indicated that a 8.6% chance exists that a 
participant randomly selected from the 6 hour after training group would have higher nausea-
related motion sickness symptoms than a participant randomly selected from the no training 
group.  
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A Mann-Whitney test was conducted to further analyze the difference found in the 
Kruskal-Wallis test. The results of this test indicated that participants in the 24 hour after training 
group suffered from less self-rated, nausea-related symptoms of motion sickness (Mdn = 19.08) 
than participants in the no training group (Mdn = 57.24) 30 minutes following exposure, U = 
15.0, p = 0.024. A nonparametric effect size estimator indicated that a 18.5% chance exists that a 
participant randomly selected from the 24 hour after training group would have higher nausea-
related motion sickness symptoms than a participant randomly selected from the no training 
group.  
A Mann-Whitney test was conducted to further analyze the difference found in the 
Kruskal-Wallis test. The results of this test showed no difference in self-rated, nausea-related 
symptoms of motion sickness between participants in the 6 hour after training group (Mdn = 
9.54) and 24 hour after training group (Mdn = 19.08) 30 minutes after exposure, U = 33.0, p = 
0.546. A nonparametric effect size estimator indicated that a 40.7% chance exists that a 
participant randomly selected from the 6 hour after training group would have higher nausea-
related motion sickness symptoms than a participant randomly selected from the 24 hours after 
training group.  
These results indicates that pre-exposure training may not have an impact on the peak 
nausea symptoms of motion sickness, but exposure to a mild motion sickness inducing event 6 
hours or 24 hours prior to the more extreme motion sickness inducing event may decrease the 
time required to recover from nausea concerns associated with motion sickness symptoms. The 
length of time between training and exposure would not appear to impact recovery from nausea 
symptoms of motion sickness. This trend can be seen in Figure 11.  
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Figure 11. SSQ Nausea Score between Groups with SSQ Nausea score on the vertical axis and 
time relative to initial OKD exposure on the horizontal axis. The time = 0 point represents the 
pre-test. A difference exists between the NT group and both PT groups at 65 minute mark. 
Asterisks indicate the presence of a significant difference, and are in the color corresponding to 
the group that is different with. Error bars are quartiles for each group. 
 
 
SSQ Oculomotor Score. A Kruskal-Wallis was conducted to compare the effect of pre-
exposure training on SSQ Oculomotor score following OKD exposure. The results of the test  
revealed no significant effect of pre-exposure training on SSQ Oculomotor score immediately 
after exposure (2(3) = 3.828, p = 0.147).  
A Kruskal-Wallis was conducted to compare the effect of pre-exposure training on SSQ 
Oculomotor score following OKD exposure.  The results of the test indicated a significant effect 
of pre-exposure training on SSQ Oculomotor score 30 minutes after exposure (2(3) = 8.856, p = 
0.012).  
A Mann-Whitney test was conducted to further analyze the difference found in the 
previous Kruskal-Wallis test.  The results of the test indicated that self-rated oculomotor 
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symptoms of motion sickness were lower in participants within the 6 hour after training group 
(Mdn = 22.74) than participants in the no training group (Mdn = 15.16) 30 minutes following 
exposure, U = 12.0, p = 0.011. A nonparametric effect size estimator indicated that a 14.8% 
chance exists that a participant randomly selected from the 6 hour after training group would 
have higher oculomotor motion sickness symptoms than a participant randomly selected from the 
no training group. 
A Mann-Whitney test was conducted to further analyze the difference found in the 
previous Kruskal-Wallis test.  The results of the test indicated that self-rated oculomotor 
symptoms of motion sickness were lower in participants within the 24 hour after training group 
(Mdn = 22.74) than participants in the no training group (Mdn = 60.64) 30 minutes following 
exposure, U = 12.5, p = 0.011. A nonparametric effect size estimator indicated that a 15.4% 
chance exists that a participant randomly selected from the 24 hour after training group would 
have higher oculomotor motion sickness symptoms than a participant randomly selected from the 
no training group. 
A Mann-Whitney test was conducted to further analyze the difference found in the 
previous Kruskal-Wallis test.  The results of the test indicated that self-rated oculomotor 
symptoms of motion sickness were no different between participants in the 6 hour after training 
group (Mdn = 22.74) and participants in the 24 hour after training group (Mdn = 15.16) 30 
minutes after exposure, U = 30.5, p = 0.387. A nonparametric effect size estimator indicated that 
a 37.7% chance exists that a participant randomly selected from the 6 hour after training group 
would have higher oculomotor motion sickness symptoms than a participant randomly selected 
from the 24 hour after training group. 
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This results indicates that pre-exposure training may not have an impact on the peak 
oculomotor symptoms of motion sickness, but exposure to a mild motion sickness inducing event 
6 hours or 24 hours prior to the more extreme motion sickness inducing event may decrease the 
time required to recover from oculomotor concerns associated with motion sickness symptoms. 
The length of time between training and exposure would not appear to impact recovery from 
oculomotor symptoms of motion sickness. This trend can be seen in Figure 12.  
 
 
 
Figure 12. SSQ Oculomotor Score between Groups with SSQ Oculomotor score on the vertical 
axis and time relative to the beginning of OKD exposure on the horizontal axis. The time = 0 
point represents the pre-test. A difference exists between the NT group and both PT groups at 65 
minute mark. Asterisks indicate the presence of a significant difference, and are in the color 
corresponding to the group that is different with. Error bars are quartiles for each group. 
 
 
SSQ Disorientation Score. A Kruskal-Wallis test was conducted to compare the effect 
of pre-exposure training on SSQ Disorientation score following OKD exposure. The results of 
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the test revealed a significant effect of pre-exposure training on SSQ Disorientation score 
immediately after exposure, 2(3) = 7.790, p = 0.02, and 30 minutes after exposure (2(3) =  
6.510, p = 0.039). A Mann-Whitney test was conducted to further analyze the difference found in 
the previous Kruskal-Wallis test.  The results of the test indicated that self-rated disorientation 
symptoms of motion sickness were lower in participants within the 6 hour after training group 
(Mdn = 97.44) than participants in the no training group (Mdn = 194.88) immediately following 
exposure, U = 9.0, p < 0.01.  A nonparametric effect size estimator indicated that a 11.1% chance 
exists that a participant randomly selected from the 6 hour after training group would have 
higher disorientation motion sickness symptoms than a participant randomly selected from the no 
training group.  
A Mann-Whitney test was conducted to further analyze the difference found in the 
previous Kruskal-Wallis test.  The results of the test indicated that self-rated disorientation 
symptoms of motion sickness were lower in participants within the 6 hour after training group 
(Mdn = 27.84) than participants in the no training group (Mdn = 83.52) 30 minutes following 
exposure, U = 13.50, p = .014. A nonparametric effect size estimator indicated that a 16.7% 
chance exists that a participant randomly selected from the 6 hour after training group would 
have higher disorientation motion sickness symptoms than a participant randomly selected from 
the no training group. 
A Mann-Whitney test was conducted to further analyze the difference found in the 
previous Kruskal-Wallis test.  The results of the test indicated that self-rated disorientation 
symptoms of motion sickness were lower in participants within the 24 hour after training group 
(Mdn = 27.84) than participants in the no training group (Mdn = 83.52) 30 minutes following 
exposure, U = 18.5, p = 0.05. A nonparametric effect size estimator indicated that a 22.8% 
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chance exists that a participant randomly selected from the 24 hour after training group would 
have higher disorientation motion sickness symptoms than a participant randomly selected from 
the no training group. 
A Mann-Whitney test was conducted to further analyze the difference found in the 
previous Kruskal-Wallis test.  The results of the test indicated that self-rated disorientation 
symptoms of motion sickness were not lower in participants within the 24 hour after training 
group (Mdn = 111.36) than participants in the no training group (Mdn = 194.88) immediately 
following exposure, U = 20.0, p = 0.077. A nonparametric effect size estimator indicated that a 
24.7% chance exists that a participant randomly selected from the 24 hour after training group 
would have higher disorientation motion sickness symptoms than a participant randomly selected 
from the no training group. 
A Mann-Whitney test was conducted to further analyze the difference found in the 
previous Kruskal-Wallis test.  The results of the test indicated that self-rated disorientation 
symptoms of motion sickness were no different between participants in the 6 hour after training 
group (Mdn = 97.44) and 24 hour after training group (Mdn = 111.36) immediately after 
exposure, U = 33.0, p = .546. A nonparametric effect size estimator indicated that a 40.7% 
chance exists that a participant randomly selected from the 6 hour after training group would 
have higher disorientation motion sickness symptoms than a participant randomly selected from 
the 24 hour after training group.  
A Mann-Whitney test was conducted to further analyze the difference found in the 
previous Kruskal-Wallis test.  The results of the test indicated that self-rated disorientation 
symptoms of motion sickness were no different between participants in the 6 hour after training 
group (Mdn = 27.84) and the 24 hour after training group (Mdn = 27.84) 30 minutes after 
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exposure, U = 39.5, p = 0.931. A nonparametric effect size estimator indicated that a 48.8% 
chance exists that a participant randomly selected from the 6 hour after training group would 
have higher disorientation motion sickness symptoms than a participant randomly selected from 
the 24 hour after training group. 
The results indicates that pre-exposure training can decrease the peak disorientation 
symptoms of motion sickness, and exposure to a mild motion sickness inducing event 6 hours to 
the more extreme motion sickness inducing event may decrease the time required to recover 
from disorientation associated with motion sickness symptoms. The length of time between 
training and exposure would not appear to impact peak disorientation symptoms of motion 
sickness. This trend can be seen in Figure 13.  
 
 
 
Figure 13. SSQ Disorientation Score between Groups with SSQ Disorientation score on the 
vertical axis and time relative to the beginning of OKD exposure on the horizontal axis. The time 
= 0 point represents the pre-test. A difference exists between the NT group and both PT groups at 
the 35 minute and 65 minute marks. Asterisks indicate the presence of a significant difference, 
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and are in the color corresponding to the group that is different with. Error bars are quartiles for 
each group. 
Cortisol level. A One-way analysis of the variance was conducted on the change in 
cortisol level, significance was not found in the first post-test (F = .738, p = .488) or the second 
post-test (F = .815, p = .605). This indicated that the cortisol level is not sensitive enough to 
identify differences between training and non-training groups. 
 
Amylase level. A One-way analysis of the variance was conducted on the change in 
amylase level, significance was not found in the first post-test (F = 3.271, p = .055) or the second 
post-test (F = .144, p = .867). This indicated that the amylase level is not sensitive enough to 
identify differences between training and non-training groups.  
 
SSS Score. A Kruskal-Wallis test revealed no significant effect of training on SSS score 
immediately following exposure (2(3) = 2.197, p = 0.333) or 30 minutes following exposure 
(2(3) =  2.062, p = 0.357).  This indicated that the SSS is not sensitive enough to identify 
differences between training and non-training groups. 
 
ANAM Switching test response time. A One-way analysis of the variance was 
conducted on ANAM Switching test response time, significance was not found in the first post-
test (F = .110, p = .896) or the second post-test (F = 1.289, p=.294). This indicates that the 
ANAM Switching test response time is not sensitive enough to identify differences between 
training and non-training groups. 
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ANAM Switching test score. A One-way analysis of the variance was conducted on 
ANAM Switching test score, significance was not found in either the first post-test (F = 1.018, p 
= .376) or the second post-test (F = .605, p = .554). This indicated that the ANAM Switching test 
score is not sensitive enough to identify differences between training and non-training groups.  
 
FTNT score. A One-way analysis of the variance was conducted on FTNT score, 
significance was not found either in the first post-test (F= 2.294, p = .123) or the second post-test 
(F = .410, p = .668). This indicated that the FTNT score is not sensitive enough to identify 
differences between training and non-training groups. 
 
Heel-to-toe balance time. A One-way analysis of the variance was conducted on heel-to-
toe balance test times, significance was not found in the first post-test (F = 3.039, p = .067) or 
the second post-test (F = .787, p = .467). This indicated that the heel-to-toe balance time is not 
sensitive enough to identify differences between training and non-training groups.  
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Discussion and Conclusions 
The findings indicate 4 of the 8 measures used in this study were able to capture the 
occurrence of motion sickness symptoms; SSQ scores, SSS scores, cortisol levels, and the 
FTNT. The amylase levels, ANAM test accuracy and response time, and heel-to-toe balance test 
each did not capture the onset of motion sickness. Future studies should have participants 
perform the heel-to-toe and FTNT tests a number of times prior to experimental exposure in 
order to achieve a standard baseline for the study. The results also confirm the ability of the 
sandpaper pattern used in this OKD as being able to induce motion sickness symptoms, as 
predicted by Rodriguez-Jimenez (2012). 
In addition, the SSQ identified differences at each time step during OKD exposure. 
Specifically, a graded response was noted, where symptoms after 10 minutes of OKD exposure 
were greater than those immediately prior to OKD exposure, symptoms after 20 minutes of OKD 
exposure were greater than those after 10 minutes of OKD exposure, and symptoms 30 minutes 
after OKD exposure were greater than those after 20 minutes of OKD exposure. Additionally, 
each time step was different from each other time step. This indicates that researchers can have a 
great control over motion sickness symptoms using the OKD, where motion sickness symptoms 
increase as time exposed to the OKD increased.  
The SSQ total and disorientation scores identified differences between the training 
groups and non-training group both immediately following OKD exposure and 30 minutes 
following OKD exposure. This indicates that the self-induced motion sickness training was 
likely successful in diminishing some motion sickness symptoms typically experienced in the 
OKD, and concurs with the results reported in both Smither et al. (2008) and Mouloua et al. 
(2005). SSQ Oculomotor and Nausea scores also indicate a decrease in symptoms due to 
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exposure to a milder motion sickness stimulus prior to a more extreme motion sickness stimulus 
during recovery 30 minutes following the exposure to the more extreme motion sickness 
inducing event. It is important to note that there is very little difference between SSQ scores 
taken while participants were experiencing the motion sickness inducing environment of the 
OKD. This indicates that pre-exposure training does not decrease the onset of motion sickness 
symptoms associated with the OKD, but rather the symptom recovery following OKD exposure. 
Nonparametric effect size estimates indicated low  values for each of the statistically 
different measures. This indicates that the effect size for these measures are high, corresponding 
to between 51% and 91% of the difference identified between the groups was due to the pre-
exposure training. Effect size was largest between 6 hour after training group and the no training 
group on almost every significant measure. This indicates that 6 hours after training may be 
closer than 24 hours after training to the optimum length of time between the completion of pre-
exposure training and experiencing a more severe motion sickness inducing event for the greatest 
reduction in motion sickness symptoms. A potential topic for future research includes further 
evaluating the length of time between the last pre-exposure training session and the more severe 
exposure to a motion sickness inducing environment. This study only evaluated the difference 
between 6 hours and 24 hours. Other times, such as 3 hours, 12 hours or 48 hours should be 
explored to further capture the impact training has on motion sickness symptoms and determine 
an optimal wait time between pre-exposure training and exposure to a more severe motion 
sickness inducing event.  
Additionally, research should be conducted to ascertain if the reduced motion sickness 
symptoms due to pre-exposure training last for more than one session. If motion sickness 
symptoms are reduced for multiple days following exposure, it is possible that the symptoms 
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could be reduced until maximum adaptation occurs. If future results indicate the effects of pre-
exposure training lasting until adaptation occurs, than cruise line, commercial space tourism 
operators, and other operations sensitive to motion sickness can recommend similar pre-exposure 
training for motion sickness sensitive passengers prior to cruise departure, spacecraft launch, or 
motion sickness event dates.  
The power estimator conducted on the SSQ Total scores indicates that the Mann-Whitney 
tests between the 6 hour after training group and the no training group had the highest power. To 
achieve similar power between the 24 hour, between 11 and 19 more participants per group 
would have been needed, which was beyond the scope of this study. The statistical power was 
expected to be lower than optimal for the nonparametric measures, as nonparametric analyses are 
known have less power (Mumby, 2002). Power estimates were only conducted on the SSQ Total 
score due to a high correlation between SSQ Total scores and SSQ scores for each of the Nausea, 
Oculomotor, and Disorientation categories. Future studies should consider increasing the number 
of participants to increase the power of self-reporting measures to levels comparable to 
calculations that can be analyzed parametrically. 
 Measures other than the SSQ did not indicate differences between groups, such as SSS 
score, cortisol levels, alpha amylase levels, cognitive performance, and the balance tests. It was 
deemed that based upon the relatively high standard deviations associated with these 
measurements, these measurements were not sensitive enough to accurately depict the changes 
expected as a result of pre-exposure training. Future studies using the ANAM Switching test 
should consider setting the initial testing benchmark at a higher value than the 90% benchmark 
that was used in this study; a score over 95% or even high would possibly lead to a greater 
impact from motion and reduce the variability seen in this study. A concern for doing this, 
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though is while this may increase the variability between participants, it may create a ceiling 
effect, where participants are unable to get results due to a lack of variability on the higher end. 
Additionally, future studies conducting biochemical assays should also consider measuring 
melatonin level, as melatonin may be useful as a non-subjective measure of fatigue and sopite.  
A possible explanation considered by the researcher for the lack of discriminating results 
from the cortisol and amylase levels relates to the motion sickness symptom curves indicated by 
these measures. Chouker et al. (2010) has shown that salivary biochemical indicators have a 
delayed appearance in test samples; in their study, salivary cortisol levels increased to peak 
during post-test collection, rather than immediately following the final exposure to their motion 
sickness inducing environment. As the curves associated with salivary cortisol and amylase only 
rise in this study, it is possible the biomarkers had just or never reached their peak, and the 
differences between groups would not have been displayed until further beyond the times which 
samples were collected as part of this study. These can be seen in Figures 7 and 8. It is possible 
that a difference between groups could have been noted if samples from participants were also 
collected 60 minutes after OKD exposure. Future research using saliva samples with motion 
sickness should consider collecting samples beyond 30 minutes following exposure to better map 
the cortisol and amylase curves associated with motion sickness as further testing was beyond 
the scope of this study.  
 No results indicated a difference between the 6 hour and the 24 hour pre-training groups. 
This indicates that the positive impacts of training are present regardless of whether exposure 
occurs 6 or 24 hours following the pre-exposure training. 
 When selecting measures for future studies measuring motion sickness symptoms, 
consideration should be made to ensure measures maintain a balance between sensitivity, the 
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ability to diagnose motion sickness, cost, effort, and the training requirement on both researchers 
and participants. This can change between testing environments and may not be the same as they 
were in this study. For this study, it was found that the SSQ was the most balanced for this 
testing environment. 
 One consideration that was not taken into account was the nature of the OKD to cause 
claustrophobia, which could present similar symptoms to those expected from motion sickness. 
The OKD is approximately 6 feet in diameter and participants were seated in the OKD for 30 
minutes during this experiment. Future research in the OKD should provide an indication that 
claustrophobia was not impacting the results by having an additional control group who sit in the 
OKD without it spinning for the length of the experiment.   
The results of this study indicate the presence of adaptation to motion sickness. The 
presence of adaptation indicates support for the Neural Mismatch theory of motion sickness. One 
point against that theory is that the adaptation was only observed as a decrease in subjective 
symptoms during the recovery from OKD exposure. Perhaps with longer or different training, 
this effect could be seen earlier in the recovery or even during the exposure. The results of this 
study confirm the results of Smither et al. (2008) indicating that pre-exposure training does have 
an impact on subjective motion sickness symptoms following OKD exposure. Additionally, it is 
possibly that the lack of a difference shown by the salivary amylase levels in this study indicates 
that norepinephrine is not a strong indicator of stress as it relates to motion sickness. Rather, it is 
possible that the stress identified by prior studies using salivary amylase could stem from the 
stress of the environment meant to induce motion sickness rather than the stress associated with 
the sickness itself.  
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While research into pre-exposure training is not complete, the results in this study may 
lead to practical application of pre-exposure training in the future. Pre-exposure training could 
increase safety during transportation in both public and private industries. If pre-exposure 
training is found to be effective in mitigating symptoms in the real world, the training could be 
initiated for military personnel prior to participating in helicopter or fixed-wing air transport 
operations to ensure that passengers being dropped off are still combat ready. Additionally, in the 
private sector, airline passengers that get air sick could possibly benefit from pre-exposure 
training to recover from symptoms following their flight. If the pre-exposure training performed 
in this study is found to be applicable to other forms of motion sickness, motion sickness 
symptom recovery could be increased in real world situations. Theme park operators could 
recommend a simple pre-exposure training the week prior to attendance so that visitors who are 
typically very sensitive to motion sickness could recover faster and enjoy more of the park. Since 
this study found no decrease in the onset or maximum symptoms, this pre-exposure training does 
not appear to be suitable for reducing motion sickness experienced during significantly longer 
motion sickness inducing environments, such as passengers on a long cruise. Future studies 
should be conducted to identify whether this holds true or not. 
 
Further Research 
There are many areas related to motion sickness which could benefit from further 
research that were beyond the scope of this study.  Further research should also consider keeping 
and evaluating participants for a full hour or more after exposure to a more severe motion 
sickness inducing event. This could identify further impacts pre-exposure training has on the 
recovery from motion sickness symptoms and could provide better insight into the biochemical 
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measures associated with motion sickness.  Another factor that was beyond the scope of the 
study was evaluating the impact of the pre-exposure training on other motion sickness inducing 
environments. A fourth area requiring further research is finding the optimum training length for 
the most efficient reduction of motion sickness symptoms. This could be accomplished by 
varying the number of days of training prior to exposure to a motion sickness inducing 
environment or varying the length of time of the training sessions.  
Another possible area of further study could be with the method of conducting the pre-
training. The method used in this study was the method used by Mouloua et al. (2005), but it 
may not be the only or the best method of performing pre-exposure training with participants 
susceptible to motion sickness symptoms. Further research should be conducted to explore these 
possibilities.  
Another area of research that should be considered is comparing the effectiveness of pre-
exposure training against the effectiveness of pharmacological countermeasures such as 
Dramamine, Chlorpheniramine, Scopolamine (Hyocine), Promethazine, Ondansetron and 
Ramosetron. These countermeasures have had mixed reports of success and can have serious 
drawbacks, but testing these pharmacological countermeasures against behavioral 
countermeasures such as pre-exposure training could reveal that pharmacological 
countermeasures are more effective or less effective that behavioral countermeasures. Side by 
side testing may also provide an indication that motion sickness symptoms may be causing the 
side effects experienced by taking pharmacological countermeasures to motion sickness. An 
example could be that the fatigue associated with these countermeasures could be the 
manifestation of sopite syndrome caused by the motion sickness inducing event rather than a side 
effect of the countermeasures. Another potential outcome of such side-by-side research could be 
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findings that indicate combining pharmacological countermeasures with behavior 
countermeasures further decreasing the impact of motion sickness symptoms.  
An additional method to test the impacts of pre-exposure training on motion sickness 
symptoms is to expose motion sickness sensitive participants to a non-laboratory motion sickness 
inducing environment after the pre-exposure training has been conducted. This could be 
accomplished through the use of a small boat being sent out on rough seas following four days of 
the mild pre-exposure training used in this study. This experiment would confirm that the pre-
exposure training is effective for mitigating motion sickness symptoms when participants are 
exposed to motion sickness inducing environments beyond just the OKD.  
Unfortunately, predicting rough seas the five days needed for training prior to sending 
participants out on a boat can be difficult, and cause participants to be trained without a 
sufficient motion sickness environment to test in. An alternative that could resolve this issue is 
the use of parabolic flight rather than a boat on rough seas. Parabolic flight in an aircraft, though 
more expensive, can be scheduled for most days and would be especially handy in areas of the 
country where storms are rare. Using parabolic flight at the motion sickness inducing 
environment would provide a better analog to the environment experienced as part of SAS than 
any environment simulated on the ground. The results such an experiment could provide 
considerable data on the usefulness of pre-exposure training on reducing symptoms associated 
with SAS and could show OKD exposure as a sufficient analog to other motion sickness 
inducing environments.  
 
 
 
65 
 
 
 
Summary 
In summary, this study found pre-exposure training to be effective in reducing motion 
sickness symptoms induced by an OKD. This study also showed no difference between 
completing the pre-exposure training 6 hours or 24 hours prior to exposure. Further, it has been 
concluded that the SSQ is the most sensitive measure for identifying changes between groups 
exposed to the same motion sickness inducing environment. The results of this study could 
provide a valuable tool for mitigating motion sickness symptoms in environments such as 
microgravity, simulators, boats, and airplanes, where motion sickness symptoms could 
negatively impact performance and safety. 
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Appendix A 
Motion Sickness Susceptibility Questionnaire 
MOTION SICKNESS SUSCEPTIBILITY QUESTIONNAIRE 
INSTRUCTIONS  
This questionnaire is primarily concerned with: (1) your susceptibility to motion sickness, and 
(2) what types of motion are the most effective in causing this sickness.  
 
Please read the questions carefully and answer them ALL by FILLING IN with an “X” in the 
boxes which most closely correspond to you as an individual.  
 
All the information you give is CONFIDENTIAL and will be used for research purposes only. 
Thank you very much for your cooperation.  
 
NAME     APPROXIMATE WEIGHT     HEIGHT   
      
EMAIL ADDRESS        TELEPHONE NUMBER   
       
GENDER      AGE 
       
 
1. In the past YEAR, how many times have you TRAVELED AS A PASSENGER in the 
following types of transport?   
 
MODE NEVER 1 2-3 4-15 16-63 64-255 256+ 
CARS        
BUSES         
COACHES        
SMALL 
BOATS 
       
SHIPS        
AEROPLANES        
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TRAINS        
  
2. In the past YEAR, how many times have you FELT ILL, whilst traveling AS A 
PASSENGER in the following types of transport?  
 
MODE NEVER 1 2 3 4-7 8-15 16+ 
CARS        
BUSES         
COACHES        
SMALL 
BOATS 
       
SHIPS        
AEROPLANES        
TRAINS        
 
3. In the past YEAR, how many times have you VOMITED, whilst traveling AS A 
PASSENGER in the following types of transport?  
 
MODE NEVER 1 2 3 4-7 8-15 16+ 
CARS        
BUSES         
COACHES        
SMALL 
BOATS 
       
SHIPS        
AEROPLANES        
TRAINS        
 
4. Do you EVER feel HOT or SWEAT whilst traveling AS A PASSENGER in the 
following types of transport? 
 
MODE NEVER OCCASIONALLY OFTEN ALWAYS  
CARS     
BUSES      
COACHES     
SMALL 
BOATS 
    
SHIPS     
AEROPLANES     
TRAINS     
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5. Do you EVER suffer from HEADACHES whilst traveling AS A PASSENGER in the 
following types of transport? 
 
MODE NEVER OCCASIONALLY OFTEN ALWAYS  
CARS     
BUSES      
COACHES     
SMALL 
BOATS 
    
SHIPS     
AEROPLANES     
TRAINS     
 
6. Do you EVER suffer from LOSS/CHANGE OF SKIN COLOR (go pale) whilst traveling 
AS A PASSENGER in the following types of transport? 
 
MODE NEVER OCCASIONALLY OFTEN ALWAYS  
CARS     
BUSES      
COACHES     
SMALL 
BOATS 
    
SHIPS     
AEROPLANES     
TRAINS     
 
7. Do you EVER suffer from MOUTH WATERING whilst traveling AS A PASSENGER 
in the following types of transport? 
 
MODE NEVER OCCASIONALLY OFTEN ALWAYS  
CARS     
BUSES      
COACHES     
SMALL 
BOATS 
    
SHIPS     
AEROPLANES     
TRAINS     
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8. Do you EVER feel DROWSY whilst traveling AS A PASSENGER in the following 
types of transport? 
 
MODE NEVER OCCASIONALLY OFTEN ALWAYS  
CARS     
BUSES      
COACHES     
SMALL 
BOATS 
    
SHIPS     
AEROPLANES     
TRAINS     
 
9. Do you EVER feel DIZZY whilst traveling AS A PASSENGER in the following types of 
transport? 
 
MODE NEVER OCCASIONALLY OFTEN ALWAYS  
CARS     
BUSES      
COACHES     
SMALL 
BOATS 
    
SHIPS     
AEROPLANES     
TRAINS     
 
10. Do you EVER suffer from NAUSEA (stomach discomfort, feeling sick) whilst traveling 
AS A PASSENGER in the following types of transport? 
 
MODE NEVER OCCASIONALLY OFTEN ALWAYS  
CARS     
BUSES      
COACHES     
SMALL 
BOATS 
    
SHIPS     
AEROPLANES     
TRAINS     
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11. Have you EVER VOMITED whilst traveling AS A PASSENGER in the following types 
of transport? 
 
MODE YES NO 
CARS   
BUSES    
COACHES   
SMALL 
BOATS 
  
SHIPS   
AEROPLANES   
TRAINS   
 
12. Would you AVOID any of the following types of transport because of motion sickness? 
MODE NEVER OCCASIONALLY OFTEN ALWAYS  
CARS     
BUSES      
COACHES     
SMALL 
BOATS 
    
SHIPS     
AEROPLANES     
TRAINS     
 
13. Which of the following best describes you SUSCEPTIBILITY to motion sickness? 
MUCH LESS THAN 
AVERAGE 
 
LESS THAN AVERAGE  
AVERAGE  
MORE THAN AVERAGE  
MUCH MORE THAN 
AVERAGE  
 
 
14. Have you ever suffered from any serious illness or injury 
YES  
NO  
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15. Are you under medical treatment or suffering a disability affecting daily life?  
YES  
NO  
 
 
Thank you for your time! 
 
(Adapted from Griffin & Howarth, 2000) 
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Appendix B  
Demographic Form 
 
(Begins on next page) 
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Demographic Form 
Please fill out all answers if applicable. All answers will be kept anonymous.  
ID # _______  Gender _______  Age ______  Weight_______ 
Do you wear glasses? (Please circle)  Yes   No 
 If yes:  All the time Sometimes Just for Distance Just for Reading 
Medications & Medical Conditions  
______________________________________________________________________________
______________________________________________________________________________
______________________________________________________________________________ 
Are you currently taking any anti-depressant medications? If so, which? 
______________________________________________________________________________
______________________________________________________________________________ 
Do you have a history of inner ear disorders or regularly have ear infections? If yes, explain. 
______________________________________________________________________________
______________________________________________________________________________
______________________________________________________________________________ 
Ethnicity (Choose one) 
 ____ American Indian or Native Alaskan 
 ____ Asian or Asian American 
 ____ Black or African American 
 ____ Hawaiian or Other Pacific Islander 
 ____ Hispanic or Latino 
 ____ Non-Hispanic White 
 ____ Other (specify): ___________ 
 
Comments:  
______________________________________________________________________________
______________________________________________________________________________  
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Appendix C 
Informed Consent Form 
 
(Begins on next page) 
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Embry-Riddle Aeronautical University 
 
Nicholas Stapleton, B.S., Principal Investigator 
Jonathan French, Ph. D., Advisor 
Thesis Research: “Pre-exposure training as a means to reduce vection induced symptoms of 
motion sickness” 
 
This Informed Consent Form has two parts: 
 Information sheet (to share information about the study with you) 
 Certificate of Consent (for signatures if you choose to participate) 
 
You will be given a copy of the full Informed Consent Form once signed 
 
Part I: Information Sheet 
 
Introduction 
The study I am conducting as part of my Master’s thesis is the evaluation of motion sickness 
symptoms induced by the Coriolis illusion (which will be demonstrated for you) and the 
optokinetic (OK) drum.  The Coriolis illusion will involve several repetitions over 4 days prior to 
the OK drum exposure, involving about 2 hours each day.   The experiment will last 5 weeks, 
only 3 of which you will be participating in. Two weeks will be considered off weeks to allow 
you to fully recover from any training effects prior to the start of the next experimental week. 
The OK drum is a device that is designed to induce symptoms of motion sickness by having the 
participant stare at a pattern rotating around their head.  For the OK drum, you will be seated 
through the 30 minutes of exposure.   
 
You must first read, understand and sign this consent document before proceeding.   If you agree 
to participate, you will first complete a Motion Sickness Susceptibility Questionnaire (MSSQ) to 
determine if you are eligible for this study.   
 
Purpose of the Research 
The induction of perceived motion through the use of visual stimuli is known as vection; this is 
the type of experience you will have in the Optokinetic drum. The corilis illusion uses the 
vestibular (balance) sense. We are interested in determining the degree of symptoms produced by 
each.    
 
Type of Research Intervention 
This research will require you to answer a series of questionnaires, providing saliva samples 
periodically (for hormone changes), and taking a cognitive test (to determine if cognitive ability 
is impaired by exposure).  The saliva samples will be processed to determine the content of the 
carbohydrate enzyme amylase and the hormones melatonin and cortisol. These samples are only 
natural biochemical agents in your body. Your DNA will not be examined during the processing 
of your saliva samples. No other agents or markers will be examined from your samples.  These 
data from your saliva samples will hopefully lead to a more useful and rational means to develop 
motion sickness drugs as countermeasures.     
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Participant Selection 
You must complete an MSSQ (Motion Sickness Susceptibility Questionnaire) in order for us to 
determine how susceptible you are for motion stimuli. In other words, this test will determine 
whether you will get motion sickness symptoms.   We only have a limited number of participants 
due to the number of chemical assays and their expense.  
 
Voluntary Participation 
Participation in this experiment is completely voluntary. You will be paid $200 for your 
participation in this study.   At any time, you may decide you do not wish to participate in this 
research.  You will be paid whatever amount you have earned up to that point.   However we 
encourage you to remain and learn something about your susceptibility to motion symptoms. 
 
  
Duration & Procedures 
This experiment requires your participation for one week. Depending on the group you are 
participating in, this means either 2 hours or 10 hours for that week.  The procedures require you 
to answer some symptom questionnaires, take cognitive tests and provide saliva samples. The 
OK drum is a fixed structure. Entering and exiting the drum will require you to climb under the 
drum on your hands and knees. The researcher will assist you if you request or require it. 
 
Risks 
As the experiment being conducted is testing for motion sickness, it is likely that you will 
experience motion sickness symptoms while participating in this test. These should not be severe 
and we will do all we can to keep them minimal.   General symptoms may include nausea, 
eyestrain, blurred vision, headache, vertigo, and stomach concerns depending on your 
susceptibility. During every stage of the experiment, you will be closely monitored by a 
researcher to ensure your comfort.  While in the OK drum, you will be observed by camera.  
This camera is not recording, only providing your current status to the researcher controlling the 
OK drum.   We expect these symptoms to be mild in most cases similar to those experienced on 
a rotating carnival ride.  Our experience has shown that the effects are quite short, and typically 
pass within an hour of onset.   You will not be able to leave the facility until your symptoms 
have subsided as determined by the questionnaire and the researcher.   
 
Additionally, the OK drum is a small space, roughly 6 feet in diameter. It is possible for 
participants sensitive to small spaces to feel claustrophobic. If the feeling of claustrophobia is 
beyond comfortable levels, report it to the researcher, who will stop the drum if it is rotating and 
assist you in leaving. 
 
Benefits 
You will be helping us to discover the effects of motion sickness behavioral countermeasures 
and to understand the neurohormonal consequences of motion sickness for the development of 
pharmaceutical countermeasures. In other words, the data you provide through your saliva 
samples helps us understand how a person reacts to motion sickness on a biological level. 
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Reimbursement 
Your participation in this study will amount to approximately $10 per hour of participation.  
 
 
Confidentiality 
Your results will be kept by the PI in a locked file cabinet and your name will not be associated 
with your results.  We will use a coding system to keep the results separate from your name. 
 
Saliva Protocol 
Your saliva sample will be kept anonymous for the duration of its existence. Samples will be 
sent to Salimetrics Inc., a reputable saliva processing facility. Samples will be stored in a secure 
biological storage refrigerator prior to shipping to Salimetrics, Inc. Your names will not be sent 
with your samples. Only the researcher will have information to match your samples to the 
remainder of your records. Samples will be stored at Salimetrics for 30 days following the 
processing. After 30 days, samples will be disposed of into a residual waste collection and 
removed with other waste from the Salimetrics facility. 
 
Sharing the Results 
The results will not be shared and will only be reported in the aggregate (averages and medians). 
 
Right to Refuse or Withdraw 
As mentioned previously, you have the right to withdraw without penalty from the experiment at 
any time. 
 
Who to Contact 
Should you have any questions, you can ask them now or any time in the future. To ask 
questions later, contact either of the following: 
 
Mr. Nicholas Stapleton, Principal Investigator 
 E-mail: staple3f@my.erau.edu 
 Call/Text: (315) 317-5837 
  
Dr. Jonathan French, Advisor 
 Phone: (386) 226-6284 
 E-mail: Frenc70f@erau.edu 
 
IRB Approval 
The Institutional Review Board of Embry-Riddle Aeronautical University has reviewed and 
approved this study to ensure the experiment is not a risk to your health and wellbeing.  
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Part II: Certificate of Consent 
 
I have read the information provided to me in Part I of the Informed Consent Form and have had 
opportunity to ask questions about it and the study. These questions have been answered to my 
satisfaction. I voluntarily consent to be a participant in this study. 
 
Print Participant Name: ___________________________ 
 
Participant Signature: _____________________________ 
 
Date:       /        /        _ 
 
Statement by the researcher/person taking consent 
 
I have read out all the information accurately to the potential participant and have, to the best of 
my ability, ensured that the participant understands the information provided to them on this 
form. I confirm that the participant was allowed the opportunity to ask questions about the study, 
and all questions were answered to the best of my ability. I also confirm that the potential 
participant has not been coerced into giving consent and the consent has been given freely and 
voluntarily.  
 
A copy of this consent form has been provided to the participant. 
 
Print Name of Researcher/Person taking consent: ___________________________ 
 
Signature of Researcher/Person taking consent: _____________________________ 
 
Date:       /        /        _ 
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Appendix D 
Simulator Sickness Questionnaire 
 
Please complete all lines of this questionnaire. Each line is a separate symptom. Circle the 
strength of each symptom you feel. 
 
1.    General discomfort  None  Slight  Moderate  Severe 
  
2.    Fatigue   None  Slight  Moderate  Severe 
 
3.   Headache   None  Slight  Moderate  Severe 
 
4.    Eyestrain   None  Slight  Moderate  Severe 
 
5.    Difficulty focusing  None  Slight  Moderate  Severe 
 
6.    Salivation increase  None  Slight  Moderate  Severe 
 
7.    Sweating   None  Slight  Moderate  Severe 
 
8.    Nausea    None  Slight  Moderate  Severe 
 
9.    Difficulty concentrating None  Slight  Moderate  Severe                                 
 
10.  Fullness of the head  None  Slight  Moderate  Severe    
 
11.  Blurred vision  None  Slight  Moderate  Severe    
 
12.  Dizziness eyes open  None  Slight  Moderate  Severe    
 
13.  Dizziness eyes close  None  Slight  Moderate  Severe    
 
14.  Vertigo   None  Slight  Moderate  Severe    
 
15.  Stomach awareness  None  Slight  Moderate  Severe    
 
16.   Burping   None  Slight  Moderate  Severe    
 
 
 
(Kennedy et al., 1993) 
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Appendix E 
Stanford Sleepiness Scale (SSS) 
The Stanford Sleepiness Scale (SSS) 
Degree of Sleepiness 
Scale 
Rating 
Feeling active, vital, alert, or wide awake 1 
Functioning at high levels, but not at peak; able to 
concentrate 
2 
Awake, but relaxed; responsive but not fully alert 3 
Somewhat foggy, let down 4 
Foggy; losing interest in remaining awake; slowed 
down 
5 
Sleepy, woozy, fighting sleep; prefer to lie down 6 
No longer fighting sleep, sleep onset soon; having 
dream-like thoughts 
7 
Asleep X 
 
 
  
86 
 
 
 
Appendix F 
Switching Test Instructions 
The Switching Test Instructions  
 
The Switching test is our cognitive assessment tool. It is a test that is entirely contained on a small USB 
computer plug-in device which you will be assigned upon entering the study. The Switching test is a 
challenging task but we are confident you will learn to do it quickly and accurately within the first 7 days 
of the study.  
 
Once started, the Switching test takes about 10 minutes. 
 
Steps 
 
1. The “Battery Selection” window will be loaded. Add you ID # _____. Click “Next”  
 
 
2. The first time you use the software and your ID # an “Information” window will appear. Click 
“Yes”. 
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3. Verify you ID # on the “Confirmation” window. Click “Yes” if correct. 
 
 
4. The “Test Settings” window will appear. Click “Next”  
 
 
5. A description about the Switching test will appear. Please take a moment to read them. Press 
the space bar on your keyboard to continue.    
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6. The next window will display actual Instructions for the test. Take a moment to read them. 
Make sure you understand them before pressing your keyboard’s space bar.     
 
 
7. The next window will display the name of the test, “Switching”. Press space bar to start the test. 
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8. A red arrow will indicate the task that needs to be answered. The red arrow will switch back and 
forth between the tasks so your job is to pay attention to when the switch occurs and answer 
the correct task. Be sure to answer quickly because the program only gives you a few seconds 
before it moves onto the next question.  
 
 
9. After finishing the test, a window will display the percent of correct answers (see a sample 
below). The researcher will record your results. Please DO NOT press the space bar.  
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If you would like more information about the Switching test or any task in this study, please feel free to 
contact Nicholas Stapleton:  
 
E-mail:  staple3f@my.erau.edu 
   
Text:   (315) 317-5837 
 
Thank you for your interest and participation!  
 
(Adapted from Rodríguez-Jiménez, 2012) 
 
 
